<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Dr Heeraj Bulluck on Medium]]></title>
        <description><![CDATA[Stories by Dr Heeraj Bulluck on Medium]]></description>
        <link>https://medium.com/@h.bulluck?source=rss-8c9f309780aa------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*sqWqrtAdrM5GmPFnN_442w.jpeg</url>
            <title>Stories by Dr Heeraj Bulluck on Medium</title>
            <link>https://medium.com/@h.bulluck?source=rss-8c9f309780aa------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Tue, 17 Nov 2026 02:26:55 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@h.bulluck/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com" rel="hub"/>
        <item>
            <title><![CDATA[You Exercised This Morning. Then You Sat for Ten Hours.]]></title>
            <link>https://medium.com/heart-reset-journal/you-exercised-this-morning-then-you-sat-for-ten-hours-b04da4f69dad?source=rss-8c9f309780aa------2</link>
            <guid isPermaLink="false">https://medium.com/p/b04da4f69dad</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[movement]]></category>
            <category><![CDATA[exercise]]></category>
            <category><![CDATA[longevity]]></category>
            <category><![CDATA[heart-health]]></category>
            <dc:creator><![CDATA[Dr Heeraj Bulluck]]></dc:creator>
            <pubDate>Fri, 13 Nov 2026 10:01:03 GMT</pubDate>
            <atom:updated>2026-11-13T10:01:03.424Z</atom:updated>
            <content:encoded><![CDATA[<h3>A 2026 meta-analysis of 39 laboratory trials found that short, frequent walking breaks reduced the rise in blood sugar after meals. The workout matters. So may the hours after it.</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*oIrC0nsx4ekc92D0YQF0Kg.png" /><figcaption>Your workout is an appointment. The rest of your day is the exposure.</figcaption></figure><h3>The 6.30am Alibi</h3><p>Ciarán is 47, a solicitor, and he runs five kilometres three mornings a week before most of his street is awake. By 8am he is in the car. By 9am he is at his desk, and apart from a sandwich eaten over email and the occasional walk to the printer, that is where he stays until six. Then dinner. Then the sofa.</p><p>His annual bloods came back “fine”. His HbA1c, a three-month average of blood sugar, was 41 mmol/mol (5.9%): just below the NICE threshold for prediabetes, but higher than it had been five years earlier. “I don’t understand it,” he told me. “I exercise.”</p><p>He does. The question nobody had asked him was what happened during the other fifteen waking hours.</p><p>Most people can tell you how long they exercised today. Very few can tell you when they last stood up.</p><h3>What the New Evidence Shows</h3><p>In May 2026, a group of New Zealand researchers published a systematic review in Obesity Reviews of laboratory trials comparing uninterrupted sitting with sitting broken up by short activity breaks [1]. Of 53 eligible studies, 39 were combined in a meta-analysis. The typical design was simple: participants sat for several hours, ate a standard meal and had their glucose and insulin measured over the hours that followed.</p><p>Breaking up sitting reduced the rise in both glucose and insulin after eating. Walking breaks produced the clearest effect. Standing breaks made little measurable difference. Frequency mattered too: breaks every 15 to 30 minutes reduced the response, while breaks only every 45 to 60 minutes did not reach statistical significance.</p><p>That fits an earlier review led by Aidan Buffey at the University of Limerick, which found that light walking lowered post-meal glucose and insulin compared with continued sitting, with a smaller effect from standing alone [2].</p><blockquote><em>Standing up is a start. In these trials, walking is what moved the numbers.</em></blockquote><p>Does it matter when you walk? In a randomised crossover study from New Zealand, published in Diabetologia in 2016, 41 adults with type 2 diabetes tried two approaches for two weeks each [3]. In one, they were advised to walk for 30 minutes a day, at any time. In the other, they walked for 10 minutes after each main meal, starting within five minutes of finishing.</p><p>On paper, the daily total was the same: 30 minutes. In the after-meals phase, the total rise in blood sugar above its starting level over the three hours after eating, measured by continuous glucose monitors, was 12 per cent lower. Researchers call this the incremental area under the curve. It is not the same as a 12 per cent lower peak. The difference was largest after the evening meal, about 22 per cent, when participants ate the most carbohydrate and were otherwise least active.</p><p>There is a catch. Participants were more active overall during the after-meals phase, so the trial cannot separate the effect of timing from the effect of simply moving more. The after-meal walk may have helped partly because it got people moving at all.</p><p>These findings need careful reading. The review’s trials were short, lab-based and small (the median study had 14 participants), and results varied considerably between them. The timing trial was small and in people who already had type 2 diabetes, so its percentages should not be transferred to everyone. None of this says anything directly about heart attacks or strokes. What they do suggest is that the hours after a meal are a useful moment to move.</p><h3>Why Muscle Is the Missing Piece</h3><p>After a meal, glucose enters the bloodstream and the body has to put it somewhere. Skeletal muscle is the largest destination. When muscle contracts, it moves glucose transporters called GLUT4 to the cell surface and draws glucose in through a pathway that works partly independently of insulin [4]. Walking recruits the biggest muscles you have: thighs, calves and glutes. A seated muscle is largely idle. A working one is taking glucose out of circulation.</p><p>Why would a cardiologist care about blood sugar after lunch? In the European DECODE analysis of more than 22,000 adults from ten cohorts, glucose measured two hours after a glucose drink predicted cardiovascular death better than fasting glucose alone [5]. That is an association. No trial has yet shown that blunting post-meal rises with walking prevents heart attacks. But the post-meal period is one of the first places metabolic strain becomes visible, often years before an HbA1c result crosses a diagnostic line.</p><p>There is a name for the movement that happens outside formal exercise: NEAT, or non-exercise activity thermogenesis. It is the energy you use walking to the shops, taking the stairs or carrying the shopping in from the car [6]. Most writing about NEAT treats it as a weight-loss story.</p><p>The blood-sugar studies are narrower than that. They tested specific walking routines, so the effects belong to walking, not to everyday movement in general. My interest is in where in the day that walking sits.</p><h3>The Myth: “My Workout Cancels Out My Desk”</h3><p>A UK Biobank analysis of 72,174 adults who wore activity trackers looked at this directly [7]. Among people sitting 10.5 hours a day or more, more daily steps were still associated with lower cardiovascular risk, with lower risk seen from around 4,300 steps and the lowest near 9,700. But for a similar number of steps, cardiovascular risk was lower in people who sat less.</p><p>A second UK Biobank analysis followed 25,241 adults who did no formal exercise at all [8]. Those who accumulated about three short bursts of vigorous everyday activity a day, such as a brisk climb up the stairs or a fast walk for the bus lasting one to two minutes, had substantially lower cardiovascular mortality over roughly seven years. Both studies are observational: people who move more differ in many other ways, so neither can prove cause and effect.</p><p>Taken together, they suggest exercise and sitting behave more like two separate accounts than one. A deposit in the first does not automatically clear the balance in the second.</p><p>Ciarán kept his morning runs. He added a ten-minute walk after dinner, began taking phone calls on his feet in the corridor, and set his watch to prompt him after 30 minutes in the chair. Nothing about it was heroic. That was the point.</p><h3>What Actually Moves This</h3><p>1. Walk after your largest meal. Ten minutes, starting within about five minutes of finishing. For most people that is dinner, which is also when the trial effect was largest [3].</p><p>2. Break up sitting every 20 to 30 minutes. Two to three minutes of light walking is the kind of break used in these studies [1, 9]. A trip to the kitchen, a lap of the floor or a call taken standing all count.</p><p>3. If you cannot leave your desk, use your legs where you are. Calf raises and half-squats were used as an alternative to walking breaks in a trial of adults with type 2 diabetes [9], although the pooled evidence for these is less consistent than for walking [1].</p><p>4. Keep the workout. Most guidelines recommend at least 150 minutes of moderate activity a week, muscle-strengthening activity, and limiting time spent sitting [10]. Movement after meals sits on top of that, not in place of it.</p><p>5. Track your longest sitting stretch, not just your steps. A step count can look healthy while hiding a four-hour block in a chair. The block is the thing to shorten.</p><p>THREE THINGS YOU CAN DO THIS WEEK:</p><p>1. Tonight, walk for 10 minutes after dinner, before you sit down.</p><p>2. Set a 30-minute movement reminder on your phone or watch for working hours.</p><p>3. On one day, note your longest unbroken stretch of sitting. The next day, try to halve it.</p><p>A habit sticks best when it is attached to something you already do, and you already finish a meal three times a day.</p><blockquote><em>Move a little, often, and especially after you eat.</em></blockquote><h3>References</h3><p>1. Gale JT, Martin H, Haszard JJ, Peddie MC. The acute effects of interrupting prolonged sitting with regular activity breaks on postprandial glucose and insulin in adults: a systematic review and meta-analysis. Obes Rev. 2026:e70152. doi:10.1111/obr.70152. <a href="https://doi.org/10.1111/obr.70152">https://doi.org/10.1111/obr.70152</a></p><p>2. Buffey AJ, Herring MP, Langley CK, et al. The acute effects of interrupting prolonged sitting time in adults with standing and light-intensity walking on biomarkers of cardiometabolic health in adults: a systematic review and meta-analysis. Sports Med. 2022;52(8):1765–1787. doi:10.1007/s40279–022–01649–4. <a href="https://doi.org/10.1007/s40279-022-01649-4">https://doi.org/10.1007/s40279-022-01649-4</a></p><p>3. Reynolds AN, Mann JI, Williams S, Venn BJ. Advice to walk after meals is more effective for lowering postprandial glycaemia in type 2 diabetes mellitus than advice that does not specify timing: a randomised crossover study. Diabetologia. 2016;59(12):2572–2578. doi:10.1007/s00125–016–4085–2. <a href="https://doi.org/10.1007/s00125-016-4085-2">https://doi.org/10.1007/s00125-016-4085-2</a></p><p>4. Richter EA, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev. 2013;93(3):993–1017. PMID: 23899560. <a href="https://pubmed.ncbi.nlm.nih.gov/23899560/">https://pubmed.ncbi.nlm.nih.gov/23899560/</a></p><p>5. DECODE Study Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001;161(3):397–405. doi:10.1001/archinte.161.3.397. <a href="https://doi.org/10.1001/archinte.161.3.397">https://doi.org/10.1001/archinte.161.3.397</a></p><p>6. Levine JA. Nonexercise activity thermogenesis (NEAT): environment and biology. Am J Physiol Endocrinol Metab. 2004;286(5):E675-E685. doi:10.1152/ajpendo.00562.2003. <a href="https://doi.org/10.1152/ajpendo.00562.2003">https://doi.org/10.1152/ajpendo.00562.2003</a></p><p>7. Ahmadi MN, Rezende LFM, Ferrari G, et al. Do the associations of daily steps with mortality and incident cardiovascular disease differ by sedentary time levels? A device-based cohort study. Br J Sports Med. 2024;58(5):261–268. doi:10.1136/bjsports-2023–107221. <a href="https://doi.org/10.1136/bjsports-2023-107221">https://doi.org/10.1136/bjsports-2023-107221</a></p><p>8. Stamatakis E, Ahmadi MN, Gill JMR, et al. Association of wearable device-measured vigorous intermittent lifestyle physical activity with mortality. Nat Med. 2022;28(12):2521–2529. doi:10.1038/s41591–022–02100-x. <a href="https://doi.org/10.1038/s41591-022-02100-x">https://doi.org/10.1038/s41591-022-02100-x</a></p><p>9. Dempsey PC, Larsen RN, Sethi P, et al. Benefits for type 2 diabetes of interrupting prolonged sitting with brief bouts of light walking or simple resistance activities. Diabetes Care. 2016;39(6):964–972. doi:10.2337/dc15–2336. <a href="https://doi.org/10.2337/dc15-2336">https://doi.org/10.2337/dc15-2336</a></p><p>10. Department of Health and Health Service Executive. Every Move Counts: National Physical Activity and Sedentary Behaviour Guidelines for Ireland. Dublin: Government of Ireland; 2024. <a href="https://www.gov.ie/en/healthy-ireland/publications/every-move-counts-national-physical-activity-and-sedentary-behaviour-guidelines-for-ireland/">https://www.gov.ie/en/healthy-ireland/publications/every-move-counts-national-physical-activity-and-sedentary-behaviour-guidelines-for-ireland/</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b04da4f69dad" width="1" height="1" alt=""><hr><p><a href="https://medium.com/heart-reset-journal/you-exercised-this-morning-then-you-sat-for-ten-hours-b04da4f69dad">You Exercised This Morning. Then You Sat for Ten Hours.</a> was originally published in <a href="https://medium.com/heart-reset-journal">Heart Reset Journal</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[I’m a Cardiologist. Winter Is Our Busiest Season.]]></title>
            <link>https://medium.com/heart-reset-journal/im-a-cardiologist-winter-is-our-busiest-season-44d35d786943?source=rss-8c9f309780aa------2</link>
            <guid isPermaLink="false">https://medium.com/p/44d35d786943</guid>
            <category><![CDATA[heart-health]]></category>
            <category><![CDATA[vaccines]]></category>
            <category><![CDATA[winter]]></category>
            <category><![CDATA[blood-pressure]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[Dr Heeraj Bulluck]]></dc:creator>
            <pubDate>Thu, 05 Nov 2026 12:52:12 GMT</pubDate>
            <atom:updated>2026-11-05T12:52:12.616Z</atom:updated>
            <content:encoded><![CDATA[<h3>Cold days push blood pressure up, flu can trigger a heart attack, and heart failure gets worse quietly over a fortnight. Here is what to do in November, for you and for your parents, before it starts.</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*UqO0U6lLtmtGs37hW8s5qg.png" /><figcaption>Cold days push blood pressure up; a warm home and a home cuff push back.</figcaption></figure><p>Every year I can tell when the clocks have gone back without looking at a calendar. The cath lab list gets longer, and admissions rise across cardiology.</p><p>It isn’t a feeling. Cold, viruses and the heart have a well-documented relationship. Most of it is predictable, and a good part of it is preventable if you act now, while the weather is still only grey.</p><p>The heart failure research below is in people aged 65 and over; the blood pressure and flu studies include younger adults. If you are in your 40s or 50s, read it twice: once for yourself, and once for the parent whose heating, jabs and medicine cupboard you may be the one checking.</p><h3>The science</h3><p>Cold and heart failure. A study published in JAMA Network Open on 29 October 2026 looked at 1,517,756 heart failure admissions among 996,312 adults aged 65 and over, drawn from a 50 per cent sample of US Medicare claims between 2007 and 2022 [1]. Each person was compared with themselves on days they were not admitted. The model’s reference point was a warm day of 24°C (75°F).</p><ul><li>On the coldest days (the coldest 1 day in 20), the odds of a heart failure admission over the next 14 days were 12 per cent higher.</li><li>On a moderately cold day, colder than about three days in four, the odds were 16 per cent higher. In the US data that band ran from roughly 0°C to 12°C (31°F to 54°F) [2].</li><li>Hot days showed no clear increase [1].</li></ul><p>That second number is the one to remember. You do not need a cold snap. An ordinary chilly week may be enough. An accompanying commentary makes the same point: moderate cold is common, so its cumulative effect may matter more than the rare extremes [2].</p><p>Two cautions. That 16 per cent is measured against a warm American reference day, so it is not the size of the winter rise to expect in Ireland or the UK. And the cold signal was not clear in every US region. This is observational data, so it shows a link, not proof that cold causes admissions. But the pattern fits what we see in hospital.</p><p>Cold and blood pressure. The largest study of season and blood pressure comes from the China Kadoorie Biobank: 506,673 adults aged 30 to 79 [3]. Average systolic pressure was 10 mmHg higher in winter than in summer. Above 5°C (41°F) outdoors, systolic pressure was about 5.7 mmHg higher for every 10°C (18°F) drop [3].</p><p>Parts of China have far harsher winters than ours, so the seasonal swing in Ireland or the UK is likely to be smaller. The more useful finding is about heating. Among people with central heating at home, mostly in one northern city, much of the link between outdoor temperature and blood pressure was not seen [3]. Their winter pressures were still higher than their summer ones, so heating blunted the rise rather than removing it. Many Irish and British homes are draughty and expensive to heat, so a warm home is worth the effort here too.</p><p>Flu and heart attacks. In a Canadian study in the New England Journal of Medicine, admissions for heart attack were about six times higher in the seven days after a laboratory-confirmed flu infection than in the year before and after (incidence ratio 6.05) [4]. The excess was gone after day seven. Other respiratory viruses were also linked with a rise, but a smaller one [4].</p><p>To keep that in proportion: the study found 20 heart attack admissions in that first week, against about 3 a week at other times [4]. The relative jump is large, but most people with flu do not have a heart attack. The risk is concentrated in people who already have narrowed arteries, which is exactly who the jab is offered to.</p><p>Does the jab protect people with heart disease? The best evidence comes from IAMI, a randomised trial of 2,571 people given a flu vaccine or a placebo in hospital shortly after a heart attack [16]. At 12 months, 2.9 per cent of the vaccinated group had died, against 4.9 per cent with placebo [16]. The combined rate of death, heart attack or stent thrombosis was also lower: 5.3 per cent versus 7.2 per cent. Heart attacks on their own were similar in both groups (2.0 per cent versus 2.4 per cent), so the benefit showed up mainly as fewer deaths rather than fewer heart attacks [16].</p><p>The trial was stopped early because of the COVID-19 pandemic, so it is smaller than planned, and it studied people in hospital after a heart attack rather than the general public. It is not proof for everyone. But for anyone living with heart disease, it is a strong reason not to skip the jab.</p><h3>The mechanism</h3><p>Cold tightens blood vessels to keep heat in. That pushes pressure up and makes the heart work harder. The UK Health Security Agency describes the same chain in its cold mortality report: blood vessels narrowing, blood pressure rising and blood clotting more readily, with the risk of death from heart and circulatory causes peaking about four to six days after a cold spell [5].</p><p>Flu adds inflammation, fever, a faster heart rate and, often, dehydration. In someone with a narrowed coronary artery, that combination can tip a stable plaque into a heart attack. In someone with a weak heart muscle, it can tip a stable week into fluid on the lungs.</p><p>Heart failure is the slow version. Ankles swell a little, breathlessness creeps up the stairs, weight goes up by a kilo or two (2 to 4 lb). Over a week or two, it can become an admission. That fits the 14-day window the Medicare study used for cold [1].</p><h3>The myth-bust</h3><p>“Winter heart problems are about extreme cold.” Not mainly. The heart failure data point at moderate, everyday cold [1][2]. Those days don’t come with a weather warning.</p><p>“The flu jab is for frail people.” It is for people at risk, and anyone with heart disease is in that group in both Ireland and the UK [6][7]. In people just out of hospital after a heart attack, it was linked with fewer deaths in a randomised trial [16].</p><p>“A cold remedy is harmless.” Some common ones can raise blood pressure or worsen heart failure. See the box below.</p><h3>What to do this month</h3><p>Get vaccinated, if you’re eligible.</p><p>Ireland (HSE, 2026/27): the flu vaccine is free for everyone aged 60 and over, for people aged 6 months and over with chronic heart disease (including after acute coronary syndrome), diabetes and other listed conditions, for pregnant women, for healthcare workers, and for carers and household contacts of people at risk [6]. The HSE recommends both flu and COVID-19 vaccines for everyone aged 60 and over and for people with certain medical conditions or a weakened immune system. They can be given at the same appointment at a GP or pharmacy [8].</p><p>UK (NHS, 2026/27): the free flu vaccine is for people aged 65 and over (including those turning 65 by 31 March 2027), for adults aged 18 to 64 with conditions such as coronary heart disease or heart failure, for pregnant women, for carers and for others [7]. The COVID-19 vaccine this autumn is for people aged 75 and over, care home residents and people with a weakened immune system [7][9]. Heart disease on its own does not qualify for the UK COVID-19 jab under 75.</p><p>The HSE notes that the flu vaccine starts working within two weeks [10]. November is not too late.</p><p>Check your blood pressure at home, properly. NICE’s method for home readings [11]:</p><ol><li>Sit down, and take two readings at least one minute apart.</li><li>Do this morning and evening, for at least four days and ideally seven.</li><li>Ignore day one, and average the rest.</li></ol><p>If you are not on treatment, a home average of 135/85 mmHg or higher, together with a clinic reading of 140/90 mmHg or higher, is how NICE confirms high blood pressure [11]. If you already take tablets, NICE’s home target is below 135/85 mmHg under the age of 80, and below 145/85 mmHg at 80 and over [11]. If your winter readings are drifting above your target, tell your GP rather than adjusting the dose yourself.</p><p>If you have heart failure, weigh yourself each morning and know your plan. A steady gain over a few days, more swelling or more breathlessness is a reason to call your team early, not to wait for the weekend.</p><p>Keep the house warm, especially the rooms where you sleep and sit.</p><blockquote><em>Cold-and-flu medicines that can push your pressure up</em></blockquote><h3>Three things this week</h3><ol><li>Book the jab if you’re eligible, flu and COVID together where offered.</li><li>Do a seven-day home blood pressure run the NICE way, and write the numbers down.</li><li>Check your medicine cupboard, and an older relative’s, for decongestant sachets and ibuprofen. Ask your pharmacist whether they suit you, and while you are there, check their heating is on.</li></ol><p>Winter fills the cardiology wards every year. It doesn’t have to fill them with you, or with your parents.</p><p>A jab, a cuff and a label read now are cheaper than a bed in January.</p><h3>References</h3><ol><li>Kuhrt N, Parthasarathi A, Bisno DI, et al. Ambient Temperature and Heart Failure Hospitalizations in Older Adults in the US. JAMA Netw Open. 2026;9(10):e2641051. doi:10.1001/jamanetworkopen.2026.41051. <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2855944">https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2855944</a></li><li>Puvvula J, Khatana SAM. Temperature and Heart Failure: The Exposure-Response Curve. JAMA Netw Open.2026;9(10):e2640735. doi:10.1001/jamanetworkopen.2026.40735. <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2855952">https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2855952</a></li><li>Lewington S, Li L, Sherliker P, et al. Seasonal variation in blood pressure and its relationship with outdoor temperature in 10 diverse regions of China: the China Kadoorie Biobank. J Hypertens. 2012. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4344838/">https://pmc.ncbi.nlm.nih.gov/articles/PMC4344838/</a></li><li>Kwong JC, Schwartz KL, Campitelli MA, et al. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. N Engl J Med. 2018;378(4):345–353. <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1702090">https://www.nejm.org/doi/full/10.1056/NEJMoa1702090</a></li><li>UKHSA. Cold mortality monitoring report: winter 2024 to 2025. <a href="https://www.gov.uk/government/statistics/cold-mortality-monitoring-report-england-winter-2024-to-2025/cold-mortality-monitoring-report-winter-2024-to-2025">https://www.gov.uk/government/statistics/cold-mortality-monitoring-report-england-winter-2024-to-2025/cold-mortality-monitoring-report-winter-2024-to-2025</a></li><li>HSE. Getting the flu vaccine. <a href="https://www.hse.ie/conditions/flu/get-vaccine/">https://www.hse.ie/conditions/flu/get-vaccine/</a></li><li>NHS. Winter vaccinations and winter health. <a href="https://www.nhs.uk/live-well/seasonal-health/keep-warm-keep-well/">https://www.nhs.uk/live-well/seasonal-health/keep-warm-keep-well/</a></li><li>HSE. HSE launches 2026–2027 Winter Vaccination Programme. <a href="https://about.hse.ie/news/hse-launches-2026-2027-winter-vaccination-programme/">https://about.hse.ie/news/hse-launches-2026-2027-winter-vaccination-programme/</a></li><li>UKHSA. Vaccine update: issue 378, October 2026. <a href="https://www.gov.uk/government/publications/vaccine-update-issue-378-october-2026/vaccine-update-issue-378-october-2026">https://www.gov.uk/government/publications/vaccine-update-issue-378-october-2026/vaccine-update-issue-378-october-2026</a></li><li>HSE. Influenza FAQ 2026/2027. <a href="https://assets.hse.ie/media/documents/Influenza_FAQ_2026_2027.pdf">https://assets.hse.ie/media/documents/Influenza_FAQ_2026_2027.pdf</a></li><li>NICE NG136. Hypertension in adults: diagnosis and management, recommendations 1.2.7 and 1.2.8 (home monitoring and diagnosis) and section 1.4 (treatment targets). <a href="https://www.nice.org.uk/guidance/ng136/chapter/Recommendations">https://www.nice.org.uk/guidance/ng136/chapter/Recommendations</a></li><li>NHS. Pseudoephedrine. <a href="https://www.nhs.uk/medicines/pseudoephedrine/">https://www.nhs.uk/medicines/pseudoephedrine/</a></li><li>MHRA Drug Safety Update. Pseudoephedrine: very rare risk of PRES and RCVS. <a href="https://www.gov.uk/drug-safety-update/pseudoephedrine-very-rare-risk-of-posterior-reversible-encephalopathy-syndrome-pres-and-reversible-cerebral-vasoconstriction-syndrome-rcvs">https://www.gov.uk/drug-safety-update/pseudoephedrine-very-rare-risk-of-posterior-reversible-encephalopathy-syndrome-pres-and-reversible-cerebral-vasoconstriction-syndrome-rcvs</a></li><li>NICE CKS. NSAIDs: prescribing issues. <a href="https://cks.nice.org.uk/topics/nsaids-prescribing-issues/management/nsaids-prescribing-issues/">https://cks.nice.org.uk/topics/nsaids-prescribing-issues/management/nsaids-prescribing-issues/</a></li><li>NHS. Ibuprofen for adults. <a href="https://www.nhs.uk/medicines/ibuprofen-for-adults/">https://www.nhs.uk/medicines/ibuprofen-for-adults/</a></li><li>Fröbert O, Götberg M, Erlinge D, et al. Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Circulation. 2021;144(18):1476–1484. doi:10.1161/CIRCULATIONAHA.121.057042</li><li>US Food and Drug Administration. FDA proposes ending use of oral phenylephrine as an OTC monograph nasal decongestant active ingredient after extensive review. 7 November 2024. <a href="https://www.fda.gov/news-events/press-announcements/fda-proposes-ending-use-oral-phenylephrine-otc-monograph-nasal-decongestant-active-ingredient-after">https://www.fda.gov/news-events/press-announcements/fda-proposes-ending-use-oral-phenylephrine-otc-monograph-nasal-decongestant-active-ingredient-after</a></li></ol><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=44d35d786943" width="1" height="1" alt=""><hr><p><a href="https://medium.com/heart-reset-journal/im-a-cardiologist-winter-is-our-busiest-season-44d35d786943">I’m a Cardiologist. Winter Is Our Busiest Season.</a> was originally published in <a href="https://medium.com/heart-reset-journal">Heart Reset Journal</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The 4.5-Minute Heart: What Small Habits Can and Cannot Do]]></title>
            <link>https://medium.com/heart-reset-journal/the-4-5-minute-heart-what-small-habits-can-and-cannot-do-9fd251b357be?source=rss-8c9f309780aa------2</link>
            <guid isPermaLink="false">https://medium.com/p/9fd251b357be</guid>
            <category><![CDATA[nutrition]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[exercise]]></category>
            <category><![CDATA[heart-health]]></category>
            <category><![CDATA[sleep]]></category>
            <dc:creator><![CDATA[Dr Heeraj Bulluck]]></dc:creator>
            <pubDate>Fri, 30 Oct 2026 10:06:54 GMT</pubDate>
            <atom:updated>2026-10-30T10:06:54.252Z</atom:updated>
            <content:encoded><![CDATA[<h3><em>A 2026 study of more than 53,000 adults found that 11 more minutes of sleep, 4.5 more minutes of brisk movement and a slightly better diet were associated with a 10 per cent lower rate of heart attacks, strokes and heart failure. As a cardiologist, I want to explain what that number means, and what it does not.</em></h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*RaF7Rb-J1nB_EhrO73J_tg.png" /><figcaption><strong>Small resets. Big returns.</strong></figcaption></figure><h3>The Hour She Did Not Have</h3><p>Siobhan is 52 and a partner in a law firm. She came to clinic with a home blood pressure average of 138/86 mmHg, an LDL cholesterol of 3.6 mmol/L (139 mg/dL) and a sleep tracker confirming what she already knew: five and a half hours on a good night.</p><p>She was not short of information. She was short of time. “I know I should exercise,” she told me. “I just do not have an hour.”</p><p>I hear a version of this most weeks. Underneath it sits an assumption that heart protection only comes in large blocks: an hour in the gym, a complete change of diet, eight hours of sleep starting on Monday. Anything smaller is treated as if it does not count, and so nothing starts at all.</p><p>A study published this year suggests that assumption deserves a second look.</p><blockquote><em>The usual assumption is that heart protection comes in hour-long blocks. The data suggest that, for people doing very little, the first few minutes may matter most.</em></blockquote><h3>What the Study Found</h3><p>In March 2026, researchers from the University of Sydney published an analysis of 53,242 adults from UK Biobank in the <em>European Journal of Preventive Cardiology</em>. None had a history of major cardiovascular disease at the start. Each wore a wrist accelerometer for a week, which measured sleep and moderate-to-vigorous physical activity (brisk walking, climbing stairs, carrying heavy shopping) instead of relying on memory. Diet was scored from a food questionnaire.</p><p>Over a median of eight years, there were 2,034 major cardiovascular events: heart attacks, strokes and episodes of heart failure.</p><p>The researchers set out to identify the smallest combined difference in sleep, activity and diet associated with a meaningful difference in risk, which they defined as 10 per cent.</p><p>The increments were small. Eleven more minutes of sleep a day, 4.5 more minutes of moderate-to-vigorous activity and a three-point higher diet score, which the authors illustrate as roughly an extra quarter cup of vegetables a day, were together associated with a 10 per cent lower rate of major cardiovascular events.</p><blockquote><em>Eleven more minutes of sleep, 4.5 more minutes of brisk movement and a little more on the plate were together associated with 10 per cent fewer cardiovascular events.</em></blockquote><p>At the other end of the scale, people with the most favourable combination of sleep and activity (8 to 9.4 hours of sleep and 42 or more minutes of brisk activity a day) had a 57 per cent lower rate of events than people in the lowest third for all three behaviours. Their diet scores, however, sat in the lowest third, so most of that difference relates to sleep and activity. Diet was the weakest of the three signals, probably in part because it rested on a single self-reported questionnaire.</p><p>The study also tested whether the three behaviours amplified one another. They did not appear to: the associations added together rather than multiplied, although the analysis was not large enough to exclude a modest interaction.</p><h3>The Comparison Behind the 10 Per Cent</h3><p>This is the detail that much of the coverage left out, and it changes how the number should be read.</p><p>The 10 per cent figure compares people at the bottom of the distribution with people just above them. The reference group slept roughly five and a half hours a night, did about seven minutes of brisk activity a day and had a low diet score. The finding is therefore most relevant to people starting from very little. It should not be extrapolated to someone who already sleeps seven hours and walks every day.</p><p>It is also a comparison between different people, not a measurement of what happened when anyone changed their habits. People who move a little more and sleep a little longer may differ in other ways, and statistical adjustment can account for some of these differences but not all of them. People in the early, undiagnosed stages of illness also tend to move less and sleep worse, which can make inactivity appear more harmful than it is. UK Biobank volunteers are healthier than the general population: only 5.5 per cent of those invited took part, and their mortality is considerably lower than that of people the same age in the wider population.</p><p>Finally, no randomised trial has yet tested whether micro habits, adopted by individuals, reduce heart attacks or strokes. The authors themselves state that intervention trials are needed to confirm their findings.</p><p>The study remains informative. It indicates where the largest relative gains are likely to lie: in people who currently do least. That is also the group most likely to believe that small changes are not worth making.</p><blockquote><em>The 10 per cent figure applies most to people starting from very little. That is also the group most likely to think small changes are not worth the effort.</em></blockquote><h3>Why the First Few Minutes Count Most</h3><p>The SPAN study (sleep, physical activity and nutrition) is consistent with other lines of evidence showing that the relationship between activity and cardiovascular risk is steepest at the lowest levels.</p><p>A 2025 meta-analysis of step-count studies in <em>The Lancet Public Health</em> found that 7,000 steps a day, compared with 2,000, was associated with a 25 per cent lower incidence of cardiovascular disease. The curve flattens at higher step counts; 10,000 steps is a reasonable aim for people already active, not a threshold below which nothing counts.</p><p>Intensity changes the arithmetic. In 25,241 UK Biobank adults who reported no formal exercise, three short bursts of vigorous everyday activity a day (a fast climb up the stairs, a hurried walk to catch a train) were associated with around half the rate of cardiovascular death over roughly seven years. Most of these bursts lasted a minute or less. A separate analysis estimated that, for cardiovascular death, one minute of vigorous activity was associated with a similar difference in risk as almost eight minutes of moderate activity.</p><p>The biological explanation is plausible. Repeated bouts of muscle contraction improve how the body handles glucose after meals: in a small laboratory study, interrupting prolonged sitting with three minutes of walking or squats every 45 minutes lowered blood glucose more than a single 30-minute walk. Over months, regular vigorous effort raises cardiorespiratory fitness, which is among the strongest predictors of cardiovascular risk. In a large meta-analysis, each one-MET increment in fitness (one MET is the energy cost of sitting at rest) was associated with around 15 per cent lower risk of coronary and cardiovascular events.</p><p>Sleep acts through different pathways, including appetite and energy intake. In a randomised trial of 80 adults with overweight who habitually slept less than six and a half hours, two weeks of individual sleep coaching extended sleep by about 1.2 hours a night and reduced energy intake by around 270 kcal a day.</p><p>These are short-term effects on physiology, measured over days or weeks. They make the cohort associations biologically plausible. They do not, on their own, show that the same changes prevent heart attacks.</p><h3>The Myth: “If It Is Not an Hour, It Does Not Count”</h3><p>Of all the beliefs I encounter in clinic, this one probably keeps the most people inactive. It treats exercise as an event to be scheduled rather than a pattern to be built, and when the hour does not materialise, nothing happens.</p><p>The evidence points the other way, with one important qualification: a small habit still needs real effort.</p><p>In a 2025 randomised trial, 77 inactive adults with an average age of 54 were asked to perform short bodyweight “exercise snacks” at home for 12 weeks. Their fitness improved no more than that of a group assigned to stretching, and blood markers of cardiometabolic health did not differ. Participants rated their effort at around 3 out of 10, which suggests that the effort needs to be enough to raise your breathing.</p><p>A second myth often travels with the first: that a habit forms in 21 days. In the best-known study of habit formation, the median time for a new daily behaviour to become automatic was 66 days, with a range of 18 to 254 days, and missing a single day did not materially affect the process. A 2024 systematic review reported similar medians. It is reasonable to expect around two months, and to keep going after a missed day.</p><p>Siobhan did not find an hour. She started with three things: climbing the four flights to her office at a pace that left her breathless, walking for ten minutes after lunch and moving her lights-out 15 minutes earlier each week until she reached an hour. Twelve weeks later the stairs were automatic, her tracker averaged a little over six hours and her home blood pressure average was 131/82 mmHg. Some of that change may reflect other factors, and her cholesterol still needs its own conversation. What had changed most was that she was no longer waiting for the right week to begin.</p><h3>What Actually Moves This</h3><p>1. <strong>Add three vigorous minutes a day.</strong> Take the stairs quickly, walk uphill briskly or carry shopping at pace, at an effort where speaking in full sentences becomes difficult. In the UK Biobank data, around three bursts of a minute or so a day were associated with about half the rate of cardiovascular death in non-exercisers.</p><p>2. <strong>Break up sitting every 45 minutes.</strong> Stand and walk, or do ten to fifteen squats, for two to three minutes. After meals, a ten-minute walk is a sensible default.</p><p>3. <strong>Move bedtime 15 minutes earlier.</strong> If you sleep less than seven hours, keep a fixed wake time and bring lights-out forward in 15-minute steps. Seven to nine hours remains the usual recommendation; the 8 to 9.4 hour range in the study reflected its sample and is not a target.</p><p>4. <strong>Make one dietary addition, not a dietary overhaul.</strong> Add a portion of vegetables to one meal a day, or replace one sugar-sweetened drink with water. The diet signal in SPAN was weak, but randomised evidence for a Mediterranean dietary pattern, notably the PREDIMED trial, is considerably stronger.</p><p>5. <strong>Anchor each habit to something you already do.</strong> “After I park, I take the stairs.” “After lunch, I walk for ten minutes.” Planning in this if-then form has a modest but consistent effect on physical activity in trials, and it removes the need to decide each day.</p><p><strong>THREE THINGS YOU CAN DO THIS WEEK:</strong></p><p>1. Choose one staircase or hill you meet every working day and climb it at a pace that makes conversation difficult.</p><p>2. Set a 45-minute reminder at your desk and move for three minutes each time it sounds.</p><p>3. Move lights-out 15 minutes earlier for the next 14 nights, keeping your wake time fixed.</p><p><strong>Routines. Small habits are most likely to last once they become automatic, and that takes around two months of repetition anchored to cues you already have.</strong></p><blockquote><em>Choose the habit you can still be doing in two months, and start it this week.</em></blockquote><h4>References and further reading</h4><p>1. Koemel NA, Biswas RK, Simpson SJ, et al. Combined variations in sleep, physical activity, and nutrition and the risk of major adverse cardiovascular events. <em>Eur J Prev Cardiol</em>. 2026. doi:10.1093/eurjpc/zwag141</p><p>2. Stamatakis E, Ahmadi MN, Gill JMR, et al. Association of wearable device-measured vigorous intermittent lifestyle physical activity with mortality. <em>Nat Med</em>. 2022;28(12):2521–2529. doi:10.1038/s41591–022–02100-x</p><p>3. Biswas RK, et al. Wearable device-based health equivalence of different physical activity intensities against mortality, cardiometabolic disease, and cancer. <em>Nat Commun</em>. 2025;16:8315. doi:10.1038/s41467–025–63475–2</p><p>4. Ding D, Nguyen B, Nau T, et al. Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis. <em>Lancet Public Health</em>. 2025;10(8):e668-e681. doi:10.1016/S2468–2667(25)00164–1</p><p>5. Gao Y, Li Q, Finni T, Pesola AJ. Enhanced muscle activity during interrupted sitting improves glycemic control in overweight and obese men. <em>Scand J Med Sci Sports</em>. 2024;34(4):e14628. doi:10.1111/sms.14628</p><p>6. Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. <em>JAMA</em>. 2009;301(19):2024–2035. doi:10.1001/jama.2009.681</p><p>7. Tasali E, Wroblewski K, Kahn E, et al. Effect of sleep extension on objectively assessed energy intake among adults with overweight in real-life settings: a randomized clinical trial. <em>JAMA Intern Med</em>. 2022;182(4):365–374. doi:10.1001/jamainternmed.2021.8098</p><p>8. Babir FJ, Islam H, McCreary S, et al. Technology-enabled exercise “snacks” are feasible to perform in a real-world setting: a randomized controlled trial. <em>Scand J Med Sci Sports</em>. 2025;35(8). doi:10.1111/sms.70117</p><p>9. Lally P, van Jaarsveld CHM, Potts HWW, Wardle J. How are habits formed: modelling habit formation in the real world. <em>Eur J Soc Psychol</em>. 2010;40:998–1009. doi:10.1002/ejsp.674</p><p>10. Gardner B, Lally P, Wardle J. Making health habitual: the psychology of ‘habit-formation’ and general practice. <em>Br J Gen Pract</em>. 2012;62(605):664–666. doi:10.3399/bjgp12X659466</p><p>11. Fry A, Littlejohns TJ, Sudlow C, et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. <em>Am J Epidemiol</em>. 2017;186:1026–1034. doi:10.1093/aje/kwx246</p><p>12. Singh B, Murphy A, Maher C, Smith AE. Time to form a habit: a systematic review and meta-analysis of health behaviour habit formation and its determinants. <em>Healthcare (Basel)</em>. 2024;12(23):2488. doi:10.3390/healthcare12232488</p><p>13. Bélanger-Gravel A, Godin G, Amireault S. A meta-analytic review of the effect of implementation intentions on physical activity. <em>Health Psychol Rev</em>. 2013;7(1):23–54.</p><p>14. Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. <em>N Engl J Med</em>. 2018;378:e34. doi:10.1056/NEJMoa1800389</p><p>15. Bulluck H. <em>Heart Reset 40: A Cardiologist’s Science-Backed Plan to Prevent Heart Disease Before It’s Too Late.</em> See the chapters on habits, walking and sleep.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9fd251b357be" width="1" height="1" alt=""><hr><p><a href="https://medium.com/heart-reset-journal/the-4-5-minute-heart-what-small-habits-can-and-cannot-do-9fd251b357be">The 4.5-Minute Heart: What Small Habits Can and Cannot Do</a> was originally published in <a href="https://medium.com/heart-reset-journal">Heart Reset Journal</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[I’m a Cardiologist. Here Is What I Tell Patients Before They Start a GLP-1.]]></title>
            <link>https://medium.com/heart-reset-journal/im-a-cardiologist-here-is-what-i-tell-patients-before-they-start-a-glp-1-940c76012505?source=rss-8c9f309780aa------2</link>
            <guid isPermaLink="false">https://medium.com/p/940c76012505</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[muscle-building]]></category>
            <category><![CDATA[glp-1]]></category>
            <category><![CDATA[heart-health]]></category>
            <category><![CDATA[weight-loss]]></category>
            <dc:creator><![CDATA[Dr Heeraj Bulluck]]></dc:creator>
            <pubDate>Fri, 23 Oct 2026 12:22:35 GMT</pubDate>
            <atom:updated>2026-10-23T12:22:35.768Z</atom:updated>
            <content:encoded><![CDATA[<h3>In a trial of 17,604 people with heart disease, a weekly GLP-1 injection lowered heart attack, stroke and cardiovascular death by 20 per cent. A separate trial showed what happens when people stop.</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*38CDiGJiKh0ro20vwfJpuQ.png" /><figcaption>The injection opens the window. Your habits decide whether it stays open.</figcaption></figure><h3>The Question Gareth Asked</h3><p>Gareth is 56 and runs the finance team of a manufacturing firm. Two years ago he had a heart attack and a stent. Since then he has taken his statin, cut back on alcohol and, eight months ago, started a weekly GLP-1 injection. He is 12 kg lighter and his blood pressure has come down.</p><p>At his review he asked one question: “Now the weight is off, can I come off the injection?”</p><p>It is a fair question. It is also the question that tells me whether someone sees the drug as a cure or as a tool.</p><blockquote><em>A GLP-1 can be an excellent tool for the heart. It is not a cure, and the evidence on stopping shows why.</em></blockquote><h3>What the Heart Trial Found</h3><p>The trial that changed the conversation was SELECT, published in the New England Journal of Medicine in 2023. It enrolled 17,604 adults aged 45 or over with a BMI of 27 or more and established cardiovascular disease: a previous heart attack, a previous stroke or symptomatic narrowing of the leg arteries. None had diabetes. Half took semaglutide 2.4 mg once a week. Half took a placebo. The average follow-up was about 40 months.</p><p>Heart attack, stroke or cardiovascular death occurred in 6.5 per cent of the semaglutide group and 8.0 per cent of the placebo group. That is a 20 per cent relative reduction.</p><p>Most of that came from fewer non-fatal heart attacks: 2.7 per cent versus 3.7 per cent, a larger fall than the headline figure. Cardiovascular deaths were also lower, 2.5 per cent versus 3.0 per cent, but that difference was not statistically confirmed.</p><p>In absolute terms, it is about 1.5 fewer major events for every 100 people treated over the trial’s average follow-up of just over three years. For people who already have heart disease, that is a meaningful result.</p><blockquote><em>Twenty per cent fewer heart attacks, strokes and cardiovascular deaths. In people who already had heart disease.</em></blockquote><p>Two details matter as much as the headline. The first is who took part: people with established disease, with an average age of 62. The second is tolerability: 16.6 per cent stopped the drug because of side effects, compared with 8.2 per cent on placebo.</p><h3>How It Works, and What We Do Not Yet Know</h3><p>GLP-1 is a hormone your gut releases after a meal. It tells the brain you are full, slows how quickly food leaves the stomach and helps the pancreas release insulin when blood sugar rises. The medicines in this class, such as semaglutide (Wegovy, Ozempic) and the newer tirzepatide (Mounjaro), copy that signal for longer and more strongly. People eat less, and most lose weight.</p><p>Weight loss on these drugs is associated with lower blood pressure and better blood sugar. A 2026 review in the American Journal of Hypertension describes a modest but consistent fall in systolic blood pressure, typically 2 to 5 mmHg.</p><p>Here is the less comfortable part. We do not fully know why the heart benefit happens. The SELECT investigators suggested it may not be explained by weight loss alone. That may prove right, but for now it is a hypothesis, not a settled fact.</p><p>Two larger questions are still open. SELECT enrolled only people who already had heart disease, so it does not show whether these drugs prevent a first heart attack in someone who is healthy but heavier than they would like. And it followed people for just over three years on average, not the twenty or thirty years many would need to keep taking the drug.</p><h3>The Myth: “Once the Weight Is Off, the Job Is Done”</h3><p>The STEP 1 trial gave adults with obesity weekly semaglutide or placebo for 68 weeks. The semaglutide group lost 17.3 per cent of their body weight on average. Treatment then stopped, and a subset was followed for another year.</p><p>By week 120 they had regained 11.6 percentage points, about two-thirds of what they had lost. Most of the improvements in blood pressure, cholesterol and blood sugar drifted back towards where they started. The authors concluded that ongoing treatment seems to be needed to keep the benefit.</p><blockquote><em>Think of a GLP-1 as a subscription, not a purchase. Cancel it, and the service stops.</em></blockquote><p>There is a second cost that the scale does not show. In a small body-scan subgroup of STEP 1, people on semaglutide lost an average of 5.8 kg of lean mass over 68 weeks. Some loss of lean tissue is expected with any large weight loss. But muscle is harder to rebuild after 50, and it matters for blood sugar, balance and independence later in life.</p><p>When we went through this, Gareth did not stop his injection. He changed his question. Instead of “When can I stop?” he asked “What has to be in place before I ever do?” He started strength training twice a week and booked his next blood tests for three months’ time. The injection stayed. The plan around it changed.</p><h3>What Actually Moves This</h3><p>1. Know which group you are in. The strongest heart-outcome evidence is in people with established heart disease and excess weight, as in SELECT, and in people with type 2 diabetes. If that describes you, a GLP-1 is worth discussing with your cardiologist or GP. If it does not, the conversation is more about weight and metabolic risk than proven heart protection.</p><p>2. Protect your muscle from the first week. UK guidance for adults is muscle-strengthening activity on at least two days a week. On a GLP-1, that matters more, not less. Include protein at every meal, and ask for a dietitian’s input if your appetite is very low.</p><p>3. Plan for stopping before you start. Agree with your prescriber what success looks like and what happens if you stop, whether that is because of side effects, cost or supply. Weight and blood pressure checks in the months after stopping can show early drift.</p><p>4. Track the numbers, not just the scale. Blood pressure, LDL cholesterol in mmol/L, HbA1c and waist measurement tell you more about heart risk than weight alone.</p><p>5. Report sudden vision changes promptly. In 2025 the European Medicines Agency concluded that a rare optic nerve condition called NAION is a very rare side effect of semaglutide, affecting up to 1 in 10,000 people. It is uncommon, but sudden loss of vision needs urgent assessment.</p><p>THREE THINGS YOU CAN DO THIS WEEK:</p><p>1. Write down your current blood pressure, LDL cholesterol, HbA1c and waist measurement. That gives you a baseline that does not depend on the scale.</p><p>2. Book two 30-minute strength sessions into your diary for this week, and treat them like meetings.</p><p>3. If you are taking a GLP-1, ask your prescriber one question at your next review: “What is our plan if I stop?”</p><p>Muscle is the part of weight loss you want to keep, and strength training is how you keep it.</p><blockquote><em>A GLP-1 can buy you time. What you build with that time is the reset.</em></blockquote><p>REFERENCES</p><p>1. Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT). N Engl J Med. 2023;389:2221–32. 17,604 adults with established cardiovascular disease and BMI 27 or more; major cardiovascular events 6.5 per cent vs 8.0 per cent (HR 0.80, 95% CI 0.72 to 0.90); non-fatal heart attack 2.7 vs 3.7 per cent (HR 0.72, 0.61 to 0.85); cardiovascular death 2.5 vs 3.0 per cent (HR 0.85, 0.71 to 1.01); mean follow-up 39.8 months.</p><p>2. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022. 17.3 per cent weight loss at week 68; 11.6 percentage points regained by week 120; most cardiometabolic gains reverted towards baseline.</p><p>3. STEP 1 (NCT03548935), <a href="http://clinicaltrials.gov/">ClinicalTrials.gov</a> results. Body-scan (DXA) subgroup: mean lean mass change of -5.8 kg at week 68 on semaglutide 2.4 mg.</p><p>4. GLP-1 receptor agonists and blood pressure: a state-of-the-art review. Am J Hypertens. 2026;39(5):611. Modest, consistent systolic reductions, typically 2 to 5 mmHg.</p><p>5. European Medicines Agency, PRAC. NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy. June 2025. Up to 1 in 10,000 people.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=940c76012505" width="1" height="1" alt=""><hr><p><a href="https://medium.com/heart-reset-journal/im-a-cardiologist-here-is-what-i-tell-patients-before-they-start-a-glp-1-940c76012505">I’m a Cardiologist. Here Is What I Tell Patients Before They Start a GLP-1.</a> was originally published in <a href="https://medium.com/heart-reset-journal">Heart Reset Journal</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The Vaping Mistake I See in the Cath Lab Every Week.]]></title>
            <link>https://medium.com/heart-reset-journal/the-vaping-mistake-i-see-in-the-cath-lab-every-week-b47e93f8c52a?source=rss-8c9f309780aa------2</link>
            <guid isPermaLink="false">https://medium.com/p/b47e93f8c52a</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[vaping]]></category>
            <category><![CDATA[heart-health]]></category>
            <category><![CDATA[smoking]]></category>
            <category><![CDATA[quit-smoking]]></category>
            <dc:creator><![CDATA[Dr Heeraj Bulluck]]></dc:creator>
            <pubDate>Thu, 15 Oct 2026 08:14:20 GMT</pubDate>
            <atom:updated>2026-10-15T08:14:20.518Z</atom:updated>
            <content:encoded><![CDATA[<h3>For someone who smokes, switching completely to a vape is one of the more useful things they can do for their arteries. For someone who has never smoked, or who is quietly doing both, the evidence points in a very different direction.</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*xnXGJysLAecYThl9_8td7g.png" /><figcaption>Safer than smoking is a comparison, not a clean bill of health.</figcaption></figure><h4><strong>The Patient Who Was “Nearly There”</strong></h4><p>Declan is a composite of several patients I have treated, but nothing in his story is unusual. He was 49, a quantity surveyor, when he came into the cath lab early on a Tuesday morning with a blocked right coronary artery. Two years earlier he had bought a vape to cut down. In one sense it had worked. He had gone from twenty cigarettes a day to five or six, mostly in the evening and at weekends.</p><p>“I was nearly there,” he said the next day, as though the hard part was already behind him.</p><p>I hear a version of this most weeks. Vaping has become the default answer to smoking, and for many people it is a reasonable one. The difficulty is that the way vapes are used in everyday life often looks very little like the way they were studied.</p><blockquote><em>For a smoker, a vape can be a way out. For someone who has never smoked, it offers no health benefit and can become a way in. Used alongside cigarettes, it may be neither.</em></blockquote><h4><strong>What the Evidence Shows About Switching</strong></h4><p>The strongest evidence concerns stopping smoking. The Cochrane living systematic review of e-cigarettes for smoking cessation, most recently updated in August 2026, now includes 90 studies, 49 of them randomised trials, with around 29,000 participants. It rates as high certainty the finding that nicotine e-cigarettes help more people stop smoking than nicotine patches or gum. In absolute terms that is roughly four additional people quitting for every 100 who try: around 8 to 10 with a vape against 6 with nicotine replacement.</p><p>There is also evidence on what happens inside the blood vessels. In the VESUVIUS trial from Dundee, published in the Journal of the American College of Cardiology in 2019, smokers of at least 15 cigarettes a day who were willing to switch were randomised to e-cigarettes with or without nicotine, while those who preferred to keep smoking formed a non-randomised comparison group; 114 participants were included in the analysis. Within one month, endothelial function, measured by how well the artery in the arm widens when blood flow increases, had improved by about 1.5 percentage points in those who switched. The improvement was seen with and without nicotine, and was larger in women. Because the comparison with continuing smokers was not randomised, it is less secure than a fully randomised design.</p><p>This is a surrogate marker, not a heart attack prevented. The investigators estimated that a sustained improvement of this size might translate into a lower cardiovascular event rate, but that is an extrapolation rather than a measured outcome. A 2025 meta-analysis in Heart reached a broadly similar conclusion: moving from cigarettes to e-cigarettes in the short to medium term may improve blood flow and blood pressure.</p><blockquote><em>Within a month of switching completely, blood vessel function measurably improved. That is a direction of travel, not a guarantee.</em></blockquote><h4>Why “Safer” Is Not “Safe”</h4><p>Most of the cardiovascular harm from a cigarette comes from burning tobacco. Combustion produces carbon monoxide, oxidising gases and fine particles that injure the lining of the arteries, make platelets more likely to clump and promote clot formation. Vaping removes combustion, which is why switching helps.</p><p>It does not remove everything. Nicotine itself raises heart rate and blood pressure through activation of the sympathetic nervous system, and the aerosol still contains ultrafine particles and aldehydes, generally at lower levels than cigarette smoke. When vapers are compared with smokers, the picture is favourable. When they are compared with people who use neither, the same Heart meta-analysis found that e-cigarette use was still associated with some degree of endothelial dysfunction.</p><p>What we do not yet have is long-term outcome data. The available evidence remains insufficient to determine reliably how long-term vaping affects the risk of heart attack, stroke or heart failure. Most vapers have used these products for only a few years, and the studies are too small and too short to exclude an effect. Larger longitudinal studies are under way, including the LIGER study from Sheffield Hallam University, which is following vapers who used to smoke, vapers who never smoked, dual users and ex-smokers who do not vape over two years.</p><p>The widely quoted figure that vaping is “95 per cent less harmful” comes from a 2015 Public Health England evidence review. It was an expert estimate of overall harm relative to smoking, not a measured 95 per cent reduction in heart attacks or strokes. It was never a statement that vaping is harmless, and it says nothing useful to someone who has never smoked.</p><blockquote><em>For a smoker, the right comparison is a cigarette. For a non-smoker, the right comparison is clean air.</em></blockquote><h4>The Myth: ‘Cutting Down Gets Me Most of the Way There’</h4><p>This is the belief I most want to correct, because it feels logical and is largely wrong for the heart.</p><p>The relationship between cigarettes and cardiovascular risk is not a straight line. A 2018 BMJ meta-analysis of 141 cohort studies found that smoking one cigarette a day carried around 46 per cent of the excess coronary heart disease risk of smoking twenty a day in men, and around 31 per cent in women. If risk rose in proportion to the number smoked, the figure would be closer to 5 per cent. A large share of the excess risk is already present at low levels of smoking.</p><p>Studies of people who both smoke and vape point the same way. In a 2022 analysis in Circulation of more than 24,000 adults followed in the US PATH study, people who both smoked and vaped did not show a clear reduction in cardiovascular disease risk compared with those who smoked cigarettes alone. Observational studies of this kind cannot prove cause and effect, and the number of events among exclusive vapers was small. The practical point still stands: replacing some cigarettes with vaping is not the same as eliminating cigarette exposure.</p><p>Stopping completely is a different story. In Framingham Heart Study data published in JAMA in 2019, former heavy smokers who had quit within the previous five years had a 39 per cent lower risk of cardiovascular disease than those who continued. Their risk remained higher than that of people who had never smoked for at least 10 to 15 years, and in one of the study cohorts for up to 25 years, which is one more reason to start the clock early. That clock starts with the last cigarette, not with a smaller number of them.</p><p>For patients like Declan, the change that works is simple to describe and harder to do: set a date and stop the remaining cigarettes altogether, rather than carrying a few alongside the vape. Any later plan to cut down or stop vaping can come once smoking has stopped, at a pace that does not put that at risk.</p><h4>What Actually Moves This</h4><p>1. If you smoke, aim to stop cigarettes completely, not just cut down. The strongest first step is support from a stop-smoking service and a conversation about licensed treatments, such as nicotine replacement therapy or prescription medicines. In Ireland that is the HSE QUIT service; in the UK, local NHS Stop Smoking Services.</p><p>2. Set a quit date rather than a reduction target. Because of the shape of the risk curve, five cigarettes a day is not a halfway point for your heart. Zero is the target.</p><p>3. Know where vaping fits, and where advice differs. Nicotine e-cigarettes can help people stop smoking, and trials suggest they may work better than nicotine replacement therapy for some smokers. National advice differs: the NHS supports vaping as a quitting aid, while the HSE does not currently recommend it, because e-cigarettes are not licensed medicines. If you do choose to vape, the harm-reduction goal is to replace cigarettes completely, not to smoke and vape together.</p><p>4. If you have never smoked, there is no cardiovascular reason to start vaping. If you already have, treat it as a nicotine dependence worth stopping, and speak to your GP or pharmacist about how.</p><p>5. If you are an ex-smoker who vapes to stay off cigarettes, staying off cigarettes comes first. Any plan to reduce or stop vaping should be realistic and should not put your abstinence from smoking at risk; there is no fixed schedule that suits everyone. Make sure your doctor knows your full smoking history, because former heavy smokers remain at higher cardiovascular risk for years, and that history may change how your overall risk is assessed.</p><h3>THREE THINGS YOU CAN DO THIS WEEK:</h3><p>1. If you smoke, choose a quit date in the next two weeks and write it down. Stoptober runs until the end of the month, which makes this a good moment.</p><p>2. Contact a stop-smoking service (HSE QUIT in Ireland, NHS Stop Smoking Services in the UK) and ask which licensed treatments suit you.</p><p>3. If you both smoke and vape, count every cigarette this week. Any number above zero is the one to work on.</p><p><em>Smoking is tied to cues such as the morning coffee, the car or the end of the working day; replacing the response to those cues, rather than only reducing the count, is what makes a switch last.</em></p><blockquote><em>If you smoke, aim for zero cigarettes. If you don’t, don’t start.</em></blockquote><h3>References</h3><p>1. Lindson N, Butler AR, McRobbie H, et al. Electronic cigarettes for smoking cessation. Cochrane Database of Systematic Reviews. 2026, Issue 8. Art. No.: <a href="http://cd010216.pub/">CD010216.pub</a>11.</p><p>2. George J, Hussain M, Vadiveloo T, et al. Cardiovascular effects of switching from tobacco cigarettes to electronic cigarettes. Journal of the American College of Cardiology. 2019;74(25):3112–3120. doi:10.1016/j.jacc.2019.09.067</p><p>3. Kundu A, Feore A, Sanchez S, et al. Cardiovascular health effects of vaping e-cigarettes: a systematic review and meta-analysis. Heart. 2025;111(13):599–608.</p><p>4. Hackshaw A, Morris JK, Boniface S, et al. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018;360:j5855.</p><p>5. Berlowitz JB, Xie W, Harlow AF, et al. E-cigarette use and risk of cardiovascular disease: a longitudinal analysis of the PATH Study (2013–2019). Circulation. 2022;145(20):1557–1559.</p><p>6. Duncan MS, Freiberg MS, Greevy RA, et al. Association of smoking cessation with subsequent risk of cardiovascular disease. JAMA. 2019;322(7):642–650.</p><p>7. McNeill A, Brose LS, Calder R, et al. E-cigarettes: an evidence update. Public Health England; 2015.</p><p>8. Exploring the Long-term Cardiovascular Effects of Vaping (LIGER). Sheffield Hallam University. <a href="http://clinicaltrials.gov/">ClinicalTrials.gov</a> NCT05757934.</p><p>9. Health Service Executive. Vaping. HSE QUIT; accessed October 2026. <a href="http://hse.ie/living-well/quit-smoking/vaping">hse.ie/living-well/quit-smoking/vaping</a>.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b47e93f8c52a" width="1" height="1" alt=""><hr><p><a href="https://medium.com/heart-reset-journal/the-vaping-mistake-i-see-in-the-cath-lab-every-week-b47e93f8c52a">The Vaping Mistake I See in the Cath Lab Every Week.</a> was originally published in <a href="https://medium.com/heart-reset-journal">Heart Reset Journal</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[I’m a Cardiologist — Relaxation Does Lower Blood Pressure — The Problem Is What Happens After Three…]]></title>
            <link>https://medium.com/heart-reset-journal/im-a-cardiologist-ff1d0bf0dd52?source=rss-8c9f309780aa------2</link>
            <guid isPermaLink="false">https://medium.com/p/ff1d0bf0dd52</guid>
            <category><![CDATA[relaxation]]></category>
            <category><![CDATA[heart-health]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[stress]]></category>
            <category><![CDATA[high-blood-pressure]]></category>
            <dc:creator><![CDATA[Dr Heeraj Bulluck]]></dc:creator>
            <pubDate>Thu, 08 Oct 2026 10:35:42 GMT</pubDate>
            <atom:updated>2026-10-08T10:37:18.577Z</atom:updated>
            <content:encoded><![CDATA[<h3>I’m a Cardiologist — Relaxation Does Lower Blood Pressure — The Problem Is What Happens After Three Months.</h3><h3>The largest review of relaxation techniques for high blood pressure found real short-term benefits and no good evidence that they last. A new wall-sit trial shows the same pattern. The plan that works is the one you will keep.</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*t5FhHIwBqpboLH0upoUE4w.png" /><figcaption>The best blood pressure plan is the one you are still following in a year.</figcaption></figure><h4>The Patient Who Was Told to Relax</h4><p>Ciarán is 49 and runs operations for a logistics firm. Two years ago he was started on a blood pressure tablet, and his clinic readings have been reassuring ever since. At his last check-up he mentioned how stretched work had become, and he was advised to try to relax. He downloaded a breathing app and used it most evenings for the first few weeks.</p><p>At my request, he measured his blood pressure at home through a quarter-end month. The average was 146/92 mmHg. Like many people with a busy travel schedule, he had been missing his tablet on two or three days most weeks. By then, the breathing app had also fallen by the wayside.</p><blockquote><em>Most blood pressure treatments work. They stop working when we stop doing them.</em></blockquote><h4>What the Largest Review Found</h4><p>In April 2025, a team funded by the UK’s National Institute for Health and Care Research published a network meta-analysis in BMJ Medicine. Webster and colleagues brought together 182 studies of stress management and relaxation techniques, including breathing exercises, meditation, yoga and tai chi, mindfulness, progressive muscle relaxation, music and psychotherapy.</p><p>Over the first three months, most techniques lowered systolic blood pressure by roughly 6 to 10 mmHg compared with no intervention, a reduction comparable to many lifestyle changes. Between three and twelve months, however, no technique showed clear evidence of benefit, and beyond a year only three studies were available. The authors rated the certainty of the evidence as low or very low.</p><p>This does not show that relaxation stops working at three months. It shows that we have no reliable evidence that it keeps working. Two independent experts who commented on the review pointed to the most likely reason: adherence. Relaxation takes far more time each day than a tablet, and the people who most need it are often the people with the least time.</p><p>NICE reached a similar conclusion. Its 2011 hypertension guidance said people might wish to try relaxation therapies but did not recommend that primary care provide them routinely. The 2019 update removed that line, judging the evidence insufficient, and listed relaxation therapies as a priority for further research.</p><blockquote><em>The short-term benefit is real. Whether it lasts depends on whether you keep doing it.</em></blockquote><h4>The Same Rule Applies to Exercise</h4><p>It would be inconsistent to hold relaxation to this standard and excuse everything else from it.</p><p>A 2023 meta-analysis of 270 randomised trials in the British Journal of Sports Medicine found that isometric exercise, such as wall sits, lowered resting systolic blood pressure by about 8 mmHg. Aerobic exercise lowered it by about 4.5 mmHg, and combined aerobic and resistance training by about 6 mmHg. These effects are in the same range as relaxation, and much of the isometric evidence also comes from short trials.</p><p>A UK randomised trial published last week adds a useful detail. Harry Swift and colleagues studied 100 adults, average age 37, with normal to high-normal blood pressure who were not taking blood pressure medication. Four weeks of wall sits three times a week lowered systolic pressure by about 9.5 mmHg compared with controls. Over the following month, those who continued three times a week ended about 14 mmHg below where they started, and those who cut back to once a week kept a smaller reduction of about 6.6 mmHg. Those who stopped returned to the level of the control group. The participants did not have high blood pressure, and the study lasted eight weeks, so it cannot tell us what happens over years.</p><p>The rule is the same for every option. Relaxation, exercise and medication all lower blood pressure while you keep doing them. The practical question is which of them you will still be doing in a year. For many busy people, that means a tablet taken at the same time every day, if one has been prescribed, plus one short habit that fits around work.</p><h4>Where Stress Shows Up in Your Numbers</h4><p>In June, I wrote about how chronic stress may reach the artery wall through inflammation. Both that pathway and the blood pressure pathway exist. Blood pressure is the one you can measure at home this week.</p><p>Stress activates the sympathetic nervous system. Heart rate rises, blood vessels tighten and blood pressure goes up. When a demanding week never lets up, readings during those hours may stay higher than the ones taken in a quiet clinic room. Some people have blood pressure that is normal in clinic but raised outside it, a pattern called masked hypertension, which I covered in an earlier article. In a 2018 meta-analysis of nine studies and nearly 15,000 people, masked hypertension was associated with roughly three times the odds of cardiovascular events compared with normal blood pressure, although the risk was lower than with sustained high blood pressure.</p><p>One limitation is worth stating. Home readings are usually taken seated, in the morning and evening, so they may still miss the highest pressures of the working day. If your home readings are borderline but you suspect your daytime pressure runs higher, 24-hour ambulatory monitoring is worth discussing with your doctor.</p><h4>The Myth: ‘It’s Only High Because I’m Stressed, So It Doesn’t Count’</h4><p>Stress does raise blood pressure readings. That part is true. The myth is that a reading raised by stress is harmless.</p><p>The artery wall is exposed to the pressure regardless of its cause. If your weeks are routinely stressful, the stress-raised reading is your blood pressure for a large part of your life.</p><p>Stress also affects blood pressure through the habits it disrupts. Tablets slip on busy days, exercise is the first thing cut from the diary, and alcohol and short sleep fill the gap. Each of these can move blood pressure, and unlike the stress itself, each can be changed this week.</p><p>Ciarán’s job did not become less demanding. He moved his tablet to the same time as his morning coffee, which he never misses, travelling or not. He added wall sits three times a week, in the evening when he would previously have opened his laptop, and kept the breathing app for nights when he wanted it. Three months later, his home average was below 135/85 mmHg, the usual home target.</p><h4>What Actually Moves This</h4><p>1. Start with wall sits. Stand with your back against a wall and slide down until your knees are bent, as if sitting on an invisible chair, at a depth you can hold with effort. Hold for up to two minutes. Trials have typically used four holds separated by two minutes of seated rest, three times a week. If two minutes is too long, start with what you can manage and build up. If your blood pressure is very high, or you have heart disease, check with your doctor first.</p><p>2. Measure at home properly. Use a validated upper-arm monitor with the right cuff size. Sit quietly for five minutes with your back supported, feet flat and arm resting at heart level, and avoid caffeine, exercise or smoking for 30 minutes beforehand. NICE suggests two readings a minute apart, morning and evening, for at least four days and ideally seven. Discard the first day and average the rest, and include at least one demanding workday. A home average of 135/85 mmHg or above is worth discussing with your doctor.</p><p>3. Put your tablets on autopilot. If you are prescribed blood pressure medication, attach it to something you do every day without fail, and set a reminder for travel days.</p><p>4. Keep relaxation if it helps you. Slow breathing, yoga or a walk without your phone can lower blood pressure in the short term. Treat it as one part of the plan rather than the whole plan, and choose the version you will sustain.</p><p>5. If stress is persistent, raise it as a health issue. Structured approaches such as cognitive behavioural therapy are worth discussing with your GP. They support blood pressure treatment; they do not replace it.</p><h3>THREE THINGS YOU CAN DO THIS WEEK:</h3><p>1. Do wall sits on three days this week, building towards four holds of up to two minutes, unless your doctor has advised otherwise.</p><p>2. Take home blood pressure readings for seven days, two in the morning and two in the evening, including at least one demanding workday.</p><p>3. Attach your blood pressure tablet (if you take one) to a fixed daily habit, and set a phone reminder for travel days.</p><p>Every blood pressure treatment works only while you keep doing it, and home readings are how you find out whether yours is still working.</p><blockquote><em>Your job may not get easier. Your numbers can still come down.</em></blockquote><h4>REFERENCES</h4><p>1. Webster et al. Effectiveness of stress management and relaxation interventions for management of hypertension and prehypertension: systematic review and network meta-analysis. BMJ Medicine. 2025. doi:10.1136/bmjmed-2024–001098.</p><p>2. Science Media Centre. Expert reaction to systematic review and network meta-analysis of relaxation techniques to manage high blood pressure. April 2025.</p><p>3. Edwards JJ, Deenmamode AHP, Griffiths M, et al. Exercise training and resting blood pressure: a large-scale pairwise and network meta-analysis of randomised controlled trials. Br J Sports Med. 2023;57(20):1317–1326. doi:10.1136/bjsports-2022–106503.</p><p>4. Swift H, et al. Isometric exercise training and blood pressure control: exploring the dose-response to training frequency in a randomised controlled trial. BMJ Open Sport Exerc Med. 2026. doi:10.1136/bmjsem-2025–003172.</p><p>5. Palla M, Saber H, Konda S, Briasoulis A. Masked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis. Integr Blood Press Control. 2018;11:11–24. doi:10.2147/IBPC.S128947.</p><p>6. National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management (NG136). 2019, updated 2023. Including Evidence review H: relaxation therapies. Superseded guidance: CG127 (2011).</p><p>7. McEvoy JW, McCarthy CP, Bruno RM, et al.; ESC Scientific Document Group. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912–4018. doi:10.1093/eurheartj/ehae178.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=ff1d0bf0dd52" width="1" height="1" alt=""><hr><p><a href="https://medium.com/heart-reset-journal/im-a-cardiologist-ff1d0bf0dd52">I’m a Cardiologist — Relaxation Does Lower Blood Pressure — The Problem Is What Happens After Three…</a> was originally published in <a href="https://medium.com/heart-reset-journal">Heart Reset Journal</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Your Coffee Is Not the Problem. Your Coffee Maker Might Be.]]></title>
            <link>https://medium.com/heart-reset-journal/your-coffee-is-not-the-problem-your-coffee-maker-might-be-99558549b33b?source=rss-8c9f309780aa------2</link>
            <guid isPermaLink="false">https://medium.com/p/99558549b33b</guid>
            <category><![CDATA[cholesterol]]></category>
            <category><![CDATA[healthy-lifestyle]]></category>
            <category><![CDATA[heart-health]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[coffee]]></category>
            <dc:creator><![CDATA[Dr Heeraj Bulluck]]></dc:creator>
            <pubDate>Thu, 01 Oct 2026 06:44:05 GMT</pubDate>
            <atom:updated>2026-10-01T06:44:05.979Z</atom:updated>
            <content:encoded><![CDATA[<h3><em>New scientific statements from the American College of Cardiology and the American Heart Association agree that moderate coffee is safe for most adults. They also agree on something far fewer people know: unfiltered coffee raises LDL cholesterol.</em></h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*hgOuRy7W8qjcuf7Ot7fSrQ.png" /><figcaption><em>Keep the habit. Change the filter.</em></figcaption></figure><h3>The Clean Diet That Did Not Add Up</h3><p>Tom is forty-nine, an operations director who reads food labels the way he reads a balance sheet. Two years ago his LDL cholesterol was 3.0 mmol/L (116 mg/dL). This year it was 3.6 mmol/L (139 mg/dL).</p><p>He had done what he was told. Olive oil instead of butter. No more bacon sandwiches. A brisk walk most lunchtimes. “So what else is there?” he asked.</p><p>I asked how he made his coffee. Two large mugs from a cafetière before eight o’clock. Then the office machine, three or four times a day.</p><p>Nobody had asked him that before. It had never crossed his mind that the method might matter.</p><blockquote><strong><em>He had changed what he ate. He had never thought about how he brewed his coffee.</em></strong></blockquote><h3>What the New Statements Say</h3><p>In September 2026, the American College of Cardiology approved a scientific statement on food and cardiovascular health, chaired by Professor Frank Hu of the Harvard T.H. Chan School of Public Health. Two months earlier, the American Heart Association published its own scientific statement on caffeine and cardiovascular disease.</p><p>On coffee, they say much the same thing. In large cohort studies, drinking 2–5 cups a day is associated with a lower risk of type 2 diabetes, cardiovascular disease, stroke, atrial fibrillation and heart failure. The ACC statement describes up to about 400 mg of caffeine a day as safe for most adults.</p><p>Most of this evidence is observational. People who drink coffee may differ from people who do not in ways a study cannot fully adjust for. So it is fair to say coffee is associated with lower risk. It is not fair to say coffee prevents heart disease.</p><p>There is one randomised trial worth knowing about. In DECAF, published in JAMA, 200 coffee drinkers with persistent atrial fibrillation or flutter were randomised after a successful cardioversion to keep drinking caffeinated coffee or to avoid all caffeine for six months. The arrhythmia came back in 47 per cent of the coffee group and 64 per cent of the abstinence group: a 39 per cent lower hazard of recurrence.</p><p>The trial was open-label, short and limited to people who already drank coffee. Even so, it challenges a long-standing reflex to stop coffee in anyone with an irregular heartbeat.</p><p>Then comes the line most people miss. Both statements say unfiltered coffee raises LDL cholesterol. The ACC statement names French press, boiled, Turkish and espresso coffee.</p><blockquote><strong><em>Coffee itself is not the villain. The question is what comes through the filter.</em></strong></blockquote><h3>Why the Filter Matters</h3><p>Coffee beans contain oily compounds called diterpenes. The one the ACC statement singles out is cafestol, which raises LDL cholesterol. Its close relative, kahweol, travels with it.</p><p>A paper filter holds most of these oils back. Methods that let them through, such as a cafetière, boiled coffee or Turkish coffee, deliver them straight into your cup.</p><p>A Swedish study published in 2025 measured this directly. Home-brewed, paper-filtered coffee contained a median of 12 mg of cafestol per litre. French press and percolator coffee contained around 90 mg per litre. Boiled coffee contained 939 mg per litre. Some espresso samples reached 2,447 mg per litre, although espresso is served in far smaller volumes.</p><p>The finding that should interest anyone with a desk job: coffee from workplace brewing machines had a median of 176 mg of cafestol per litre, roughly fifteen times the paper-filtered level. The authors concluded that insufficiently filtered coffee at work could be an overlooked factor in cholesterol. The study was small, eleven brewing machines in Swedish workplaces, so your office may differ.</p><p>Why would an oil in coffee change your blood test? Laboratory research suggests cafestol acts on the way the liver handles cholesterol, so less LDL is cleared from the blood. More LDL particles circulating for longer means more cholesterol delivered into the artery wall. That is how plaque builds, quietly, over years.</p><blockquote><strong><em>Paper-filtered coffee: around 12 mg of cafestol per litre. Office brewing machines: a median of 176.</em></strong></blockquote><h3>The Myth: ‘Coffee Is Bad for Your Heart’</h3><p>Plenty of people cut coffee because someone once told them it was bad for the heart. For most adults, the evidence does not support that.</p><p>Blood pressure is the usual worry. Caffeine can raise blood pressure in people who do not normally drink it, but the ACC statement notes that tolerance develops with regular use. The AHA describes an inverse J-shaped relationship between naturally caffeinated drinks and blood pressure: moderate habitual intake sits at the reassuring end, with less reassurance at high intakes.</p><p>Palpitations are the other. The AHA statement notes that, in randomised data among regular coffee drinkers, caffeinated coffee increased the frequency of extra beats from the lower chambers of the heart, called premature ventricular contractions. They can feel like a thump or a skipped beat. If you notice them, cutting back is reasonable and worth discussing with your doctor.</p><p>Where caution is real is high-dose caffeine. The AHA statement says data on energy drinks are limited but generally suggest cardiovascular harm. The reassurance about coffee does not transfer to a can of energy drink.</p><p>And people genuinely differ. The ACC statement points to genetics, age, pregnancy, medicines and underlying conditions as reasons the same cup affects two people differently.</p><p>Tom kept his coffee. He swapped the cafetière for a pour-over cone with paper filters and started taking a flask of filter coffee to work. At his next blood test, his LDL was 3.1 mmol/L (120 mg/dL). Coffee will not be the whole explanation for everyone. For Tom, it was the missing piece.</p><h3>What Actually Moves This</h3><p>1. <strong>Brew through paper if your LDL is above target.</strong> Drip machines with paper filters and pour-over cones hold back most of the cholesterol-raising oils.</p><p>2. <strong>Ask about the office machine.</strong> If you drink several cups a day at work, you probably do not know whether that machine filters the oils. The Swedish data suggest many do not filter them well. A flask of filter coffee from home removes the guesswork.</p><p>3. <strong>Keep caffeine to about 400 mg a day.</strong> The ACC statement frames moderate intake as 2–5 standard cups (240 mL each) of filtered coffee or tea.</p><p>4. <strong>Count the espressos.</strong> Espresso is on the ACC statement’s unfiltered list. The cups are small, so the dose depends on how many you drink. If your LDL is high and you have several a day, they are worth counting.</p><p>5. <strong>Recheck rather than guess.</strong> If you change how you brew, tell your doctor and compare your LDL at your next routine blood test. Coffee is one contributor. Your overall eating pattern, your genetics and, when needed, medication remain the main levers.</p><p><strong>THREE THINGS YOU CAN DO THIS WEEK:</strong></p><p>1. Count how many cups you drink on a normal day and how each is made: cafetière, espresso, office machine or paper filter.</p><p>2. If two or more are unfiltered and your LDL is above target, switch those to paper-filtered coffee for the next three months.</p><p>3. Find your last LDL result and write it down with the date, so you have a baseline to compare against.</p><p>How a drink is prepared can change what reaches your bloodstream, not just what you choose to consume.</p><blockquote><strong>Your coffee is not the problem. Your coffee maker might be.</strong></blockquote><h4><strong>References</strong></h4><p>1. Hu FB, Beleslin B, Blaha MJ, Kris-Etherton PM, Seligman HK, Williams KA Sr. Food and health: nutrition for prevention and management of cardiovascular disease: 2026 ACC scientific statement. J Am Coll Cardiol. 2026. doi:10.1016/j.jacc.2026.08.025. Filtered coffee (2–5 cups, up to about 400 mg caffeine) safe for most adults; unfiltered coffee raises LDL through cafestol.</p><p>2. Marcus GM, Hu FB, van Dam RM, et al. Caffeine and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2026;154:e345–e355. doi:10.1161/CIR.0000000000001454. Unfiltered coffee raises LDL; inverse J-shaped relationship with blood pressure; energy drinks generally suggest harm.</p><p>3. Wong CX, Cheung CC, Montenegro G, et al. Caffeinated coffee consumption or abstinence to reduce atrial fibrillation: the DECAF randomized clinical trial. JAMA. 2026;335:317–325. 200 patients after cardioversion; AF or flutter recurrence 47 versus 64 per cent (HR 0.61, 95% CI 0.42–0.89).</p><p>4. Orrje E, Fristedt R, Rosqvist F, Landberg R, Iggman D. Cafestol and kahweol concentrations in workplace machine coffee compared with conventional brewing methods. Nutr Metab Cardiovasc Dis. 2025;35:103933. doi:10.1016/j.numecd.2025.103933. Workplace brewing machines median 176 mg/L cafestol versus 12 mg/L for paper-filtered coffee.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=99558549b33b" width="1" height="1" alt=""><hr><p><a href="https://medium.com/heart-reset-journal/your-coffee-is-not-the-problem-your-coffee-maker-might-be-99558549b33b">Your Coffee Is Not the Problem. Your Coffee Maker Might Be.</a> was originally published in <a href="https://medium.com/heart-reset-journal">Heart Reset Journal</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[I Open Blocked Arteries for a Living. The Most Dangerous Thing Patients Tell Me Is “I Feel Fine.”]]></title>
            <link>https://medium.com/heart-reset-journal/i-open-blocked-arteries-for-a-living-the-most-dangerous-thing-patients-tell-me-is-i-feel-fine-bf56d59f900f?source=rss-8c9f309780aa------2</link>
            <guid isPermaLink="false">https://medium.com/p/bf56d59f900f</guid>
            <category><![CDATA[healthy-lifestyle]]></category>
            <category><![CDATA[health]]></category>
            <category><![CDATA[heart-disease]]></category>
            <category><![CDATA[heart-health]]></category>
            <category><![CDATA[longevity]]></category>
            <dc:creator><![CDATA[Dr Heeraj Bulluck]]></dc:creator>
            <pubDate>Tue, 29 Sep 2026 09:42:36 GMT</pubDate>
            <atom:updated>2026-09-29T09:42:36.964Z</atom:updated>
            <content:encoded><![CDATA[<h3><em>Today is World Heart Day, and this year’s theme is Don’t Miss a Beat: the hidden signs of heart disease. As an interventional cardiologist, the hidden sign I worry about most is the one that feels like nothing at all.</em></h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*26LfBMNGLid59lkhBLArpQ.png" /><figcaption><em>This World Heart Day, find out what yours are.</em></figcaption></figure><p>Many of the people I meet in the cath lab felt fine the week before.</p><p>Not “a bit off”. Not quietly ignoring chest pain. Fine.</p><h3>The Man Who Felt Fine</h3><p>Let me introduce Tom. He is a composite of patients I see every month. He is 49 and runs a logistics business. He cycles on Sundays, sleeps about six hours on weeknights and hasn’t seen his GP in three years because there’s been no reason to.</p><p>At a workplace health check his blood pressure is 136/84. The nurse calls it borderline. Tom hears “fine for now” and goes back to work.</p><p>Nothing about Tom looks like a heart patient. That is exactly the problem.</p><blockquote><em>Feeling fine is not the same as being low risk.</em></blockquote><h3>Why Feeling Fine Tells You So Little</h3><p>Atherosclerosis starts decades before anyone notices it. In our twenties and thirties, LDL cholesterol particles slip beneath the lining of the arteries, particularly where that lining has been damaged by raised blood pressure, high blood sugar or smoking. The immune system responds, and over years a fatty, inflamed plaque forms.</p><p>You feel none of it, because there are no pain nerves inside the artery wall.</p><p>When a heart attack does happen, it usually starts with a plaque rupturing and a clot forming on top. The clinical research is consistent on an uncomfortable point: many heart attacks arise from plaques that were not severely narrowing the artery beforehand. They caused no angina, and they may not have shown up on an exercise test.</p><blockquote><em>Symptoms are lagging indicators. By the time the body screams, the process has usually been running for decades.</em></blockquote><h3>The Hidden Signs Are Numbers</h3><p>The World Heart Federation estimates that cardiovascular disease kills more than 20 million people a year, and that 80 per cent of those deaths are caused by risk factors that can be prevented or managed. In the UK alone, according to the British Heart Foundation, there is roughly one cardiovascular death every three minutes.</p><p>This year’s campaign is about hidden signs. From where I sit, the most important hidden signs aren’t symptoms. They are five numbers most people never look at together.</p><p><strong>1. Blood pressure.</strong> Aim for under 120/80 mmHg. It is the single biggest modifiable risk factor, and most people with raised blood pressure feel nothing.</p><p><strong>2. The third number.</strong> Subtract your bottom reading from your top one. That gap is your pulse pressure, and around 40 is typical. As arteries stiffen, the gap widens: 150/70 gives 80. It is most informative from our fifties onwards, and a wider gap can be normal in young, fit adults, but a gap that stays above 60 is worth discussing with your doctor.</p><p><strong>3. LDL cholesterol.</strong> Under 2.6 mmol/L for most lower-risk adults. The target tightens as risk rises, to under 1.8 in higher-risk people and under 1.4 after a heart attack or stroke.</p><p><strong>4. HbA1c.</strong> This is your three-month blood sugar average. In the UK, 42 to 47 mmol/mol is the prediabetes range. Prediabetes isn’t pre-anything: it is often the visible end of years of insulin resistance.</p><p><strong>5. Waist-to-height.</strong> Keep your waist under half your height. BMI cannot see visceral fat, the fat packed around the organs that is associated with higher blood pressure and insulin resistance.</p><p>None of these diagnoses disease on its own, and every one of them needs clinical context. Together, they are the closest thing to a dashboard your arteries have.</p><h3>The Myth: “Borderline Means I’ve Got Time”</h3><p>When Tom finally had a proper check, nothing was dramatic. His blood pressure was 136/84, his LDL 3.8 mmol/L and his HbA1c 44 mmol/mol, and at 178 cm tall his waist measured 101 cm.</p><p>Borderline, everywhere.</p><p>Borderline is not a safe middle ground. It is the on-ramp. Each of those numbers tends to drift in one direction unless something changes. The good news is that the on-ramp is also the easiest place to turn around.</p><p>Tom didn’t overhaul his life. He walked for ten minutes after dinner, swapped his afternoon fizzy drink for water, added two short strength sessions a week and started checking his blood pressure at home. His GP talked through a statin with him, which is not failure. It was his waist that moved first.</p><blockquote><em>You don’t need perfection. You need direction.</em></blockquote><h3>What Actually Moves These Numbers</h3><p><strong>Walk for ten minutes after your main meal.</strong> Working muscles take up glucose and blunt the post-meal spike. Over time, regular walking is associated with lower blood pressure and better sleep.</p><p><strong>Follow the 3+2 rule.</strong> Three cardio sessions a week, such as a brisk walk, a cycle or a swim, plus two strength sessions. Build towards 150 minutes of moderate activity a week.</p><p><strong>Protect seven to nine hours of sleep.</strong> Even a week of short nights is associated with worse insulin resistance and higher blood pressure.</p><p><strong>Break up sitting.</strong> For every 30 minutes in a chair, move for two.</p><p><strong>Take blood pressure seriously.</strong> In a large 2016 Lancet meta-analysis, each 10 mmHg reduction in systolic pressure was associated with around a fifth fewer major cardiovascular events.</p><p>THREE THINGS YOU CAN DO THIS WEEK:</p><ol><li><strong>Tonight:</strong> work out your pulse pressure from your last reading, and measure your waist against half your height.</li><li><strong>This week:</strong> get your blood pressure checked. In England, pharmacies offer free checks if you are over 40.</li><li><strong>Today:</strong> send this to one person you love who keeps saying they feel fine.</li></ol><p>If you have chest pain on exertion, unusual breathlessness, palpitations or blackouts, do not wait for a routine check. Seek medical attention promptly.</p><blockquote><em>You cannot change what you do not measure.</em></blockquote><h3>References</h3><ol><li>World Heart Federation. World Heart Federation launches 2026 Don’t Miss a Beat campaign to highlight hidden symptoms of heart disease. Geneva: WHF; 2026. Available from: <a href="https://world-heart-federation.org/news/world-heart-federation-launches-2026-dont-miss-a-beat-campaign-to-highlight-hidden-symptoms-of-heart-disease/">https://world-heart-federation.org/news/world-heart-federation-launches-2026-dont-miss-a-beat-campaign-to-highlight-hidden-symptoms-of-heart-disease/</a></li><li>McGill HC Jr, McMahan CA, Herderick EE, Malcom GT, Tracy RE, Strong JP. Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr. 2000;72(5 Suppl):1307S–1315S.</li><li>Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92(3):657–671.</li><li>British Heart Foundation. UK Cardiovascular Disease Factsheet. London: BHF; January 2026. Available from: <a href="https://www.bhf.org.uk/-/media/files/for-professionals/research/heart-statistics/bhf-cvd-statistics-uk-factsheet-jan26.pdf">https://www.bhf.org.uk/-/media/files/for-professionals/research/heart-statistics/bhf-cvd-statistics-uk-factsheet-jan26.pdf</a></li><li>Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104.</li><li>Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111–188.</li><li>National Institute for Health and Care Excellence. Type 2 diabetes: prevention in people at high risk. Public health guideline PH38. London: NICE; 2012 (updated 2017).</li><li>National Institute for Health and Care Excellence. Overweight and obesity management. NICE guideline NG246. London: NICE; 2025.</li><li>Buffey AJ, Herring MP, Langley CK, Donnelly AE, Carson BP. The acute effects of interrupting prolonged sitting time in adults with standing and light-intensity walking on biomarkers of cardiometabolic health in adults: a systematic review and meta-analysis. Sports Med. 2022;52(8):1765–1787. doi:10.1007/s40279–022–01649–4</li><li>Bull FC, Al-Ansari SS, Biddle S, Borodulin K, Buman MP, Cardon G, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451–1462.</li><li>Buxton OM, Pavlova M, Reid EW, Wang W, Simonson DC, Adler GK. Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes. 2010;59(9):2126–2133.</li><li>Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–967.</li><li>NHS England. NHS Community Pharmacy Blood Pressure Check Service. Available from: <a href="https://www.england.nhs.uk/primary-care/pharmacy/pharmacy-services/nhs-community-pharmacy-blood-pressure-check-service/">https://www.england.nhs.uk/primary-care/pharmacy/pharmacy-services/nhs-community-pharmacy-blood-pressure-check-service/</a></li></ol><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=bf56d59f900f" width="1" height="1" alt=""><hr><p><a href="https://medium.com/heart-reset-journal/i-open-blocked-arteries-for-a-living-the-most-dangerous-thing-patients-tell-me-is-i-feel-fine-bf56d59f900f">I Open Blocked Arteries for a Living. The Most Dangerous Thing Patients Tell Me Is “I Feel Fine.”</a> was originally published in <a href="https://medium.com/heart-reset-journal">Heart Reset Journal</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[I’m a Cardiologist — here’s What Food I would Actually Recommend to My Patients]]></title>
            <link>https://medium.com/heart-reset-journal/im-a-cardiologist-here-s-what-food-i-would-actually-recommend-to-my-patients-0c9489a10efa?source=rss-8c9f309780aa------2</link>
            <guid isPermaLink="false">https://medium.com/p/0c9489a10efa</guid>
            <category><![CDATA[heart-health]]></category>
            <category><![CDATA[longevity]]></category>
            <category><![CDATA[healthy-eating]]></category>
            <category><![CDATA[aging]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[Dr Heeraj Bulluck]]></dc:creator>
            <pubDate>Thu, 24 Sep 2026 10:47:38 GMT</pubDate>
            <atom:updated>2026-09-24T10:47:38.626Z</atom:updated>
            <content:encoded><![CDATA[<h3>A decade of opening blocked arteries has changed what ends up on my plate far more than any nutrition headline ever has. Two trials shaped it more than the rest combined.</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*4tZYspxLbUSKyyPL7N7ggw.png" /><figcaption>What lands on your plate three times a day is one of the few risk factors you get to rewrite starting tonight.</figcaption></figure><h3>The Patient Who Looked Fine on Paper</h3><p>Priya was 47, a management consultant who spent four days a week living out of an overnight bag between London, Manchester and whichever client needed her most that quarter. Her specialism was risk: helping boards decide how much of it to take on, and how much to walk away from. She had never quite turned that same discipline on her own risk portfolio.</p><p>She came in for a routine executive health check, expecting little more than a tick on a list. Her cholesterol panel came back within range, and her GP’s risk score put her comfortably in the low-risk band. On paper, she looked like someone with plenty of runway left.</p><p>What her diary told me was more interesting than her bloods. Breakfast was usually a hotel buffet pastry eaten at a departure gate. Lunch was whatever the service station or the client’s canteen offered. Dinner, more often than she liked, was a meal deal eaten at her desk. Nobody’s diary looks dramatic. That is rather the point.</p><p>I recognised more of Priya in myself than I expected to. Cardiology trains you thoroughly in what damages an artery. It trains you far less in what you personally eat for lunch on a Tuesday between two cath lab lists. Over the past decade, watching plaque behave the way it does in people who were told they were fine, I have quietly rebuilt my own plate. Not around a diet. Around a handful of trials that actually changed my mind.</p><blockquote><em>A reassuring risk score does not audit what is actually on your plate.</em></blockquote><h3>The Science That Actually Changed My Plate</h3><p>Two studies did more to reshape what I eat than anything from medical school.</p><p>The first is PREDIMED, a Spanish trial published in the New England Journal of Medicine, in a corrected 2018 re-analysis after protocol deviations were identified in the original 2013 paper. It followed 7,447 adults aged 55 to 80 who were at high cardiovascular risk but had no existing heart disease, for a median of 4.8 years. One group was asked to add at least 50 grams (roughly four tablespoons) of extra-virgin olive oil to their day. A second group was asked to add 30 grams of mixed nuts daily: 15 grams walnuts, 7.5 grams almonds, 7.5 grams hazelnuts. A third followed general low-fat advice.</p><p>Major cardiovascular events (heart attack, stroke or cardiovascular death) occurred in 3.8 per cent of the olive oil group, 3.4 per cent of the nut group and 4.4 per cent of the control group, a hazard ratio of 0.69 for the olive oil arm and 0.72 for the nut arm compared with control. That is a meaningfully lower rate of events in both intervention groups. Not a rounding error.</p><p>The second is a 2019 BMJ study from the French NutriNet-Sante cohort, following 105,159 adults for a median of 5.2 years. For every 10 percentage point rise in the share of someone’s diet made up of ultra-processed food, overall cardiovascular disease risk was 12 per cent higher, coronary heart disease risk 13 per cent higher and cerebrovascular disease risk 11 per cent higher. The association held even after separately accounting for saturated fat, sodium, sugar and fibre intake.</p><blockquote><em>A ten percentage point rise in the ultra-processed share of someone’s diet was associated with a twelve per cent rise in cardiovascular disease risk. Not by removing a single food. By shifting a proportion.</em></blockquote><p>Neither trial supports fearing a single ingredient or banning a food group. Together they support a pattern: more olive oil, nuts and whole foods, less of the ultra-processed volume that has quietly become the default. That is a different instruction to “eat clean”, and a far more useful one.</p><h3>Why Pattern Beats Any Single Nutrient</h3><p>The honest mechanism is less about individual nutrients and more about structure.</p><p>Extra-virgin olive oil and nuts are rich in monounsaturated fats and polyphenols, plant compounds that are associated with improved endothelial function: the ability of the blood vessel lining to relax and regulate blood flow. Soluble fibre, found in oats, beans and lentils, binds bile acids in the gut, which in turn is associated with lower LDL cholesterol, the cholesterol most standard blood tests report first.</p><p>Ultra-processed foods work against this in a different way. It is rarely the fat, sugar or salt in isolation that does the damage. It is what the manufacturing process has stripped out of the food’s original structure, its fibre matrix, that changes how quickly the body absorbs the fat and sugar that remain. Faster absorption drives sharper glucose and insulin swings. Repeated over years, that pattern is associated with higher triglycerides, more visceral fat and, indirectly, higher blood pressure.</p><blockquote><em>It is rarely the fat, sugar or salt in isolation that does the damage. It is what the food’s structure has been stripped of that changes how the body responds to all three.</em></blockquote><p>None of this shows that any single meal causes disease. What decades of this kind of evidence does suggest is that the cumulative pattern, repeated most days for years, shapes cardiovascular risk more than any one ingredient can on its own.</p><blockquote><em>The Myth: “My Numbers Came Back Fine, So My Diet Must Be, Too”</em></blockquote><p>This is the myth I hear most often, usually from people who are otherwise careful about their health. A cholesterol panel and a risk score both come back reassuring, and the conversation about diet quietly ends there.</p><p>A standard lipid panel reports total cholesterol, HDL cholesterol and triglycerides together. Most risk scores, including the NHS’s QRISK tool, are built from a set of standard inputs: your age, blood pressure, smoking status and the ratio between your total cholesterol and your HDL cholesterol, among others. That is a sound way to estimate population risk, but it was never designed to ask what you had for lunch. Triglycerides sit on the same panel and move with diet more than the other numbers do, which is exactly why they are so often the quiet one.</p><p>A single triglyceride reading does not diagnose disease on its own, and it needs to be read alongside the rest of the panel and the pattern over time. But a borderline result, repeated quietly year after year, is not nothing.</p><p>Priya’s cholesterol ratio was reassuring, and her QRISK score reflected that. Her triglycerides, sitting at the upper edge of the healthy range on the same report, were the number nobody had actually discussed with her. Over the following months, without a dramatic overhaul, she shifted her pattern rather than chasing a single figure: more olive oil and nuts in place of the pastries, a tin of lentils or beans instead of a meal deal at her desk, oily fish worked back in twice a week rather than not at all. When we rechecked her panel some months later, her triglycerides had moved into a more reassuring range. I would not claim her diet alone did that, or that it will hold without the rest of her routine catching up too, but the direction of travel was the one the evidence would predict.</p><h3>What Actually Moves This</h3><p>This is, roughly, what I recommend to my own patients, and what ends up on my own plate for the same reasons. Call it the five positions I actually hold in my own risk portfolio, not the ones on a client-facing slide.</p><p>1. Extra-virgin olive oil as the default fat. Around 50 grams (four tablespoons) a day, across cooking and salads, in place of refined oils. This is the amount used in the PREDIMED olive oil arm.</p><p>2. A daily handful of unsalted mixed nuts. Around 30 grams: roughly 15 grams walnuts, 7.5 grams almonds, 7.5 grams hazelnuts, matching the PREDIMED nut protocol. Eaten as a snack, not after dinner, when it is more likely to simply add calories rather than replace a less useful one.</p><p>3. Oily fish, two portions a week: salmon, mackerel or sardines rather than a fish oil supplement. That is the target I set for my own patients, a notch above the floor set by the 2021 European Society of Cardiology prevention guideline, which makes oily fish at least once weekly a Class I recommendation.</p><p>4. Thirty grams of fibre a day, not the roughly 20 grams most UK adults currently manage. Oats, lentils, beans and vegetables, built up gradually to avoid the bloating that comes with a sudden jump. A 2019 Lancet analysis of dietary fibre found that, when comparing intake bands, the greatest reduction in all-cause and cardiovascular mortality was seen at 25 to 29 grams a day, though the data suggested even higher intakes may confer further benefit.</p><p>5. Salt under 5 grams a day, the World Health Organization’s recommended ceiling. In practice this means cooking more from base ingredients and checking labels on the processed foods that remain, rather than adding less salt to food that was already high in it.</p><p>None of this is a single fix, and none of it will undo established disease on its own. It is marginal gains, repeated most days for years. Not a single trade that rescues the portfolio overnight.</p><p>THREE THINGS YOU CAN DO THIS WEEK:</p><p>1. Replace one processed lunch with something built from a base ingredient (a tin of beans, a fillet of fish, a bowl of vegetables) at least three times this week.</p><p>2. Add a 30-gram handful of unsalted nuts to your day, in place of a packaged snack, not after your evening meal.</p><p>3. Check the salt content on the three most common packaged foods in your cupboard, and see how close a normal day already brings you to the World Health Organization’s 5-gram daily limit.</p><blockquote><em>What lands on your plate most days moves your cardiovascular risk far more reliably than any single food you avoid once.</em></blockquote><p>REFERENCE LIST</p><p>1. PREDIMED (corrected 2018 re-analysis): New England Journal of Medicine, 2018.</p><p>2. NutriNet-Sante cohort (Srour et al): BMJ, 2019.</p><p>3. Carbohydrate quality and human health (Reynolds et al): The Lancet, 2019.</p><p>4. Guideline: Sodium intake for adults and children: World Health Organization, 2012.</p><p>5. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: European Heart Journal, 2021.</p><p>6. QRISK3 risk prediction algorithm (Hippisley-Cox et al): BMJ, 2017.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=0c9489a10efa" width="1" height="1" alt=""><hr><p><a href="https://medium.com/heart-reset-journal/im-a-cardiologist-here-s-what-food-i-would-actually-recommend-to-my-patients-0c9489a10efa">I’m a Cardiologist — here’s What Food I would Actually Recommend to My Patients</a> was originally published in <a href="https://medium.com/heart-reset-journal">Heart Reset Journal</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The Blind Spot in Women’s Heart Risk Scores]]></title>
            <link>https://medium.com/heart-reset-journal/the-blind-spot-in-womens-heart-risk-scores-b84b53ff9259?source=rss-8c9f309780aa------2</link>
            <guid isPermaLink="false">https://medium.com/p/b84b53ff9259</guid>
            <category><![CDATA[womens-health]]></category>
            <category><![CDATA[menopause]]></category>
            <category><![CDATA[pregnancy]]></category>
            <category><![CDATA[heart-health]]></category>
            <category><![CDATA[health]]></category>
            <dc:creator><![CDATA[Dr Heeraj Bulluck]]></dc:creator>
            <pubDate>Thu, 17 Sep 2026 07:57:19 GMT</pubDate>
            <atom:updated>2026-09-17T07:57:19.574Z</atom:updated>
            <content:encoded><![CDATA[<h3><em>Two European cardiology guidelines now treat a complicated pregnancy as a cardiovascular red flag. The standard risk calculators most of us are assessed with still don’t ask about it.</em></h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*MCPWpF-_10TLZhglalhJ0Q.png" /><figcaption>The story your heart needed was already written, years before anyone thought to read it.</figcaption></figure><h3>The Check-Up That Cleared Her</h3><p>Amara is 43, a deputy head at a busy secondary school. She booked her Health Check between parents’ evenings, expecting fifteen routine minutes.</p><p>Her cholesterol was fine. Her blood pressure was fine. Her QRISK score came back under 10 per cent. Menopause had not started.</p><p>She left feeling cleared.</p><p>What the appointment never asked about was sitting in a folder from fifteen years earlier: a first pregnancy complicated by pre-eclampsia, and a second, two years later, with gestational diabetes. Both are recorded in her maternity notes. Neither came up in her cardiovascular risk conversation, because the standard form never asked.</p><blockquote>A woman’s cardiovascular risk does not start at menopause. For a meaningful number of women, it starts in the delivery room.</blockquote><h3>What Two ESC Guidelines Now Say</h3><p>Hypertensive disorders of pregnancy, meaning gestational hypertension and pre-eclampsia, affect roughly one in ten pregnancies. A 2019 review in Heart by Benschop and colleagues put the later-life cardiovascular risk in these women at, on average, twofold that of women with normotensive pregnancies.</p><p>Gestational diabetes sits in a similar, if somewhat wider, range. A 2019 systematic review and meta-analysis in Diabetologia by Kramer, Campbell and Retnakaran found a twofold increased risk of cardiovascular events after gestational diabetes, rising to 2.3-fold in the first postpartum decade, while a large Danish sibling-matched cohort put the more conservative figure at a 40 per cent increase in overall cardiovascular risk. That early spike is not because the absolute risk suddenly jumps. It is because a woman’s peers are otherwise at the lowest cardiovascular risk of their lives in their thirties and forties, so even a moderate excess stands out sharply against that low baseline. The exact multiplier depends on the study and the follow-up window. The direction does not change: risk is higher throughout, and higher earliest.</p><p>Two recent European Society of Cardiology guidelines have caught up with this evidence. The 2024 ESC Guidelines for the management of elevated blood pressure and hypertension explicitly name a history of pregnancy complications, including gestational diabetes, gestational hypertension, pre-term delivery, pre-eclampsia, stillbirth, and recurrent miscarriage, as a sex-specific risk modifier. For anyone whose calculated risk falls in the borderline 5 to 10 per cent band, that history is now a formal reason to reclassify them toward treatment rather than routine review.</p><p>The 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy, presented at the ESC Congress in Madrid and chaired by Professor Julie De Backer and Professor Kristina Haugaa, go further still. They introduce a life-course framework running from preconception through the postpartum years, and they call for structured surveillance and long-term follow-up after any adverse pregnancy outcome, precisely because that outcome is now understood as an early marker of future cardiovascular risk, not a closed chapter.</p><blockquote>For gestational diabetes specifically, the excess cardiovascular risk is highest in the first decade after delivery. It is not a distant, midlife event. It can already be building while a woman is still in her thirties.</blockquote><h3>Why Pregnancy Behaves Like a Stress Test</h3><p>Pregnancy places a genuine load on the cardiovascular and metabolic systems. Blood volume expands by up to half, the heart’s output rises substantially, and the body is pushed towards a more insulin-resistant state to feed a growing placenta. Researchers increasingly describe pregnancy as a physiological stress test: a nine-month window in which an underlying vulnerability, one that might otherwise stay hidden for another twenty years, can be unmasked early.</p><p>In pre-eclampsia, placental factors trigger widespread dysfunction in the lining of blood vessels, the endothelium, the same tissue implicated decades later in atherosclerosis. Whether this reflects pregnancy causing lasting vascular injury, an underlying predisposition to cardiovascular disease that was already present before conception and simply revealed by it, or some combination of both, is still being worked out. Current evidence supports all three possibilities and does not yet allow a woman to be told with certainty which one applies to her.</p><p>Gestational diabetes appears to work in a related but distinct way. The insulin resistance that pregnancy reveals does not always fully resolve after delivery. Meta-analysis data show measurable differences as early as one year postpartum: modestly higher blood pressure and LDL cholesterol, higher triglycerides and glucose, and lower HDL cholesterol in women with a history of gestational diabetes compared with those without. None of these differences is large in isolation. Together, over decades, they are associated with a threefold increase in the risk of metabolic syndrome.</p><blockquote>The vessels and metabolism that were pushed hard during pregnancy do not necessarily return all the way back to where they started once the pregnancy ends.</blockquote><h3>The Myth: ‘My Heart Check Was Normal, So My Risk Is Low.’</h3><p>This is the most common misreading I see of a genuinely useful tool. QRISK3, the risk calculator NICE recommends across UK primary care, and SCORE2, its equivalent used across much of continental Europe, are both good at what they were built and validated to do. Neither was built with a field for reproductive history. QRISK3 has no dedicated variable for pre-eclampsia, gestational diabetes, or recurrent miscarriage. A 2025 study that tried adding those factors on top of the existing QRISK3 model found only a marginal improvement in how well it predicted risk, precisely because the base tool was never designed to hold that information in the first place.</p><p>A successor tool, QRISK4, has since been developed and externally validated by the same Oxford research group behind QRISK3. It adds pre-eclampsia as a new risk factor for women, alongside postnatal depression, which is genuine progress. It still does not add gestational diabetes, gestational hypertension, recurrent miscarriage, or stillbirth. And it has not yet replaced QRISK3 in UK general practice. The calculator actually used at most Health Checks today remains the one with no dedicated field for any of this history.</p><p>A normal score from either tool is real information. It is not the complete interview. It tells you where you stand on the variables it was built to measure: age, blood pressure, cholesterol, smoking, and a handful of others. It says nothing at all about a chapter of your medical history that both major cardiology bodies now treat as clinically important.</p><p>Amara returned to her practice with her maternity notes. Her GP added pre-eclampsia and gestational diabetes to her problem list and moved her from a five-yearly Health Check rhythm to annual blood pressure and lipid review. Nothing about her original, technically accurate, normal result would have triggered that change on its own.</p><h3>What Actually Moves This</h3><p>None of this requires a new test that does not yet exist. It requires the history that already sits in your notes to reach the conversation where it matters.</p><p>1. Locate your own maternity notes, or request a summary from your hospital’s records office, and note specifically whether you had pre-eclampsia, gestational hypertension, gestational diabetes, three or more miscarriages, or a stillbirth.</p><p>2. Say the history out loud at your next GP appointment or Health Check. In the UK, ask directly whether it has been added to your record as a risk modifier; under current NICE-recommended practice, QRISK3 will not surface it automatically. Across the EU, the same history is now formally grounds under the 2024 ESC hypertension guideline to reclassify a borderline SCORE2 result.</p><p>3. If you had a hypertensive pregnancy, ask about yearly blood pressure checks rather than waiting for the standard review interval. Postpartum hypertension can re-emerge well before your fifties, not only after menopause.</p><p>4. If you had gestational diabetes, ask for a fasting glucose or HbA1c and a lipid panel, even if you were told your glucose tolerance test result had returned to normal after delivery.</p><p>5. If you are managing PCOS or reached menopause before 45, mention both explicitly. Neither is captured by default in QRISK3 or SCORE2, though both are recognised in the wider cardiology literature as female-specific factors that raise lifetime risk.</p><h3>THREE THINGS YOU CAN DO THIS WEEK</h3><p>1. Find your maternity notes or hospital discharge summary and write down any pregnancy complication by name: pre-eclampsia, gestational hypertension, gestational diabetes, recurrent miscarriage, or stillbirth.</p><p>2. Take your blood pressure at home on two separate days this week, same arm, same time of day, and keep the numbers.</p><p>3. Book, or extend, your next GP or Health Check appointment specifically to raise this history and ask whether it changes your risk classification.</p><blockquote><em>The record already exists in your own notes. Bringing it into today’s conversation, rather than leaving it filed away, is the single highest-leverage step in this article.</em></blockquote><h4><strong>References:</strong></h4><ul><li>Benschop L, Duvekot JJ, Roeters van Lennep JE. Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy. <em>Heart</em>. 2019;105(16):1273–1278. doi:10.1136/heartjnl-2018–313453</li><li>Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. <em>Diabetologia</em>. 2019;62(6):905–914. doi:10.1007/s00125–019–4840–2</li><li>Yu Y, Soohoo M, Sørensen HT, Li J, Arah OA. Gestational diabetes mellitus and the risks of overall and type-specific cardiovascular diseases: a population- and sibling-matched cohort study. <em>Diabetes Care</em>. 2022;45(1):151–159. doi:10.2337/dc21–1018</li><li>McEvoy JW, McCarthy CP, Bruno RM, et al.; ESC Scientific Document Group. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. <em>Eur Heart J</em>. 2024;45(38):3912–4018. doi:10.1093/eurheartj/ehae178</li><li>De Backer J, Haugaa KH, et al.; ESC Scientific Document Group. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy. <em>Eur Heart J</em>. 2025. doi:10.1093/eurheartj/ehaf193</li><li>Hippisley-Cox J, Coupland CAC, Bafadhel M, Russell REK, Sheikh A, Brindle P, Channon KM. Development and validation of a new algorithm for improved cardiovascular risk prediction. <em>Nat Med</em>. 2024;30:1440–1447. doi:10.1038/s41591–024–02905-y</li><li>Wambua S, Crowe FL, Thangaratinam S, O’Reilly D, McCowan C, Brophy S, Yau C, Nirantharakumar K, Riley RD, Snell KIE; MuM-PreDiCT Group. Development and validation of a postpartum cardiovascular disease risk prediction model in women incorporating reproductive and pregnancy-related predictors. <em>BMC Med</em>. 2025;23:508. doi:10.1186/s12916–025–04229–1</li><li>National Institute for Health and Care Excellence. Cardiovascular disease: risk assessment and reduction, including lipid modification. NICE guideline NG238. December 2023. <a href="http://www.nice.org.uk/guidance/ng238">www.nice.org.uk/guidance/ng238</a></li></ul><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b84b53ff9259" width="1" height="1" alt=""><hr><p><a href="https://medium.com/heart-reset-journal/the-blind-spot-in-womens-heart-risk-scores-b84b53ff9259">The Blind Spot in Women’s Heart Risk Scores</a> was originally published in <a href="https://medium.com/heart-reset-journal">Heart Reset Journal</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>